The disclosure relates generally to the field of implantable medical devices. More particularly, the disclosure relates to intraluminal support frames and medical devices. Particular embodiments relating to intraluminal valve devices and support frames suitable for use in such devices are described in detail.
Expandable intraluminal support frames have proven useful in the medical arts. Some expandable support frames are useful without inclusion of any additional elements. Stents, for example, are routinely used in several body lumens as a means for providing support to ailing vessels, such as coronary and non-coronary vessels. In some medical devices, an expandable support frame provides a scaffold onto which one or more additional elements can be attached to achieve a desired function. Occlusion devices, for example, often include a graft or other sheet-like material attached to an expandable support frame.
Constructed in this way, these medical devices can be delivered and deployed intraluminally to substantially block fluid flow through a body vessel. Similarly, some valve devices include a leaflet or leaflets attached to an expandable support frame in a manner that allows the leaflet or leaflets to move between open and closed positions. Constructed in this way, these medical devices can be delivered and deployed intraluminally to regulate fluid flow through a body vessel.
Considering these roles of intraluminal support frames in the medical arts, a need exists for improved frames. Furthermore, for the various types of intraluminal medical devices that include a support frame and one or more additional elements, a need exists for improved frames that improve the effectiveness of the composite device.
Valve devices provide an example. Several researchers have pursued the development of prosthetic valves that are implantable by minimally invasive techniques. Indeed, the art now contains several examples of implantable venous valve devices. Many of these prior art devices include an expandable support frame and an attached graft member that is fashioned into a valve that regulates fluid flow through the device and, ultimately, a body vessel. For example, a graft member can be in the form of a leaflet that is attached to a support frame and movable between first and second positions. In a first position, the valve is open and allows fluid flow to proceed through a vessel in a first direction, and in a second position the valve is closed to prevent fluid flow in a second, opposite direction. Examples of this type of prosthetic valve are described in commonly owned U.S. Pat. No. 6,508,833 to Pavcnik for a MULTIPLE-SIDED INTRALUMINAL MEDICAL DEVICE, which is hereby incorporated by reference in its entirety.
Despite this and other examples, a need remains for improved medical devices, including implantable valve devices, that include an expandable support frame.
Various example support frames and medical devices are described and illustrated herein.
An example support frame comprises a first circumferential serpentine path; a second circumferential serpentine path; a first connector segment joining the first and second serpentine paths, the first connector segment comprising substantially parallel first and second struts; a second connector segment disposed substantially opposite the first connector segment with respect to the longitudinal axis of the support frame and joining the first and second serpentine paths, the second connector segment comprising substantially parallel third and fourth struts; a third connector segment disposed circumferentially adjacent the first and second connector segments and joining the first and second serpentine paths; a fourth connector segment disposed substantially opposite the third connector segment and joining the first and second serpentine paths; a first connector strut extending between and joining the first and third connector segments; and a second connector strut extending between and joining the second and third connector segments.
An example medical device comprises an expandable support frame having a longitudinal axis, an outer circumference, an unexpanded configuration, and an expanded configuration with an expanded configuration radius extending from the longitudinal axis to the outer circumference; a first leaflet attached to the support frame along a first attachment pathway, the first leaflet having a first inner surface that defines a domed radius equal to or less than the expanded configuration radius when the support frame is in the expanded configuration; and a second leaflet attached to the support frame along a second attachment pathway, the second leaflet having a second inner surface that defines a second domed radius equal to or less than the expanded configuration radius when the support frame is in the expanded configuration.
Another example medical device comprises an expandable support frame having a longitudinal axis, an outer circumference, an unexpanded configuration, and an expanded configuration with an expanded configuration radius extending from the longitudinal axis to the outer circumference. For this example medical device, the expandable support frame comprises a first circumferential serpentine path; a second circumferential serpentine path; a first connector segment joining the first and second serpentine paths, the first connector segment comprising substantially parallel first and second struts; a second connector segment disposed substantially opposite the first connector segment with respect to said longitudinal axis and joining the first and second serpentine paths, the second connector segment comprising substantially parallel third and fourth struts; a third connector segment disposed circumferentially adjacent the first and second connector segments and joining the first and second serpentine paths; a fourth connector segment disposed substantially opposite the third connector segment and joining the first and second serpentine paths; a first connector strut extending between and joining the first and third connector segments; and a second connector strut extending between and joining the second and third connector segments. This example medical device includes a leaflet attached to the support frame along an attachment pathway extending along the first and second connector struts and along a portion of the first connector segment and a portion of the second connector segment, the leaflet having an inner surface that defines a domed radius equal to or less than the expanded configuration radius when the support frame is in the expanded configuration. The domed radius can be any suitable domed radius, including a domed radius that is between about ⅛th the expanded configuration radius and the expanded configuration radius, a domed radius that is between about ¼th the expanded configuration radius and about ¾th the expanded configuration radius, and a domed radius that is about ¼th the expanded configuration radius.
Another example medical device is similar to the example medical device described above, but also includes a second leaflet attached to the support frame along a second attachment pathway extending along the third and fourth connector struts and along a portion of the first connector segment and a portion of the second connector segment. Similar to the first leaflet, the second leaflet can have a domed radius equal to or less than the expanded configuration radius when the support frame is in the expanded configuration. For the second leaflet, the domed radius can be any suitable domed radius, including a domed radius that is between about ⅛th the expanded configuration radius and the expanded configuration radius, a domed radius that is between about ¼th the expanded configuration radius and about ¾th the expanded configuration radius, and a domed radius that is about ¼th the expanded configuration radius.
In another example medical device having first and second leaflets, as briefly described above, the first and second leaflets have domed radii that are substantially equal. In another example medical device having first and second leaflets, as briefly summarized above, the first and second leaflets have domed radii that are equal.
Additional understanding of the inventive support frames and medical devices can be obtained with review of the detailed description, below, and the appended drawings.
The following detailed description and the appended drawings describe and illustrate various example support frames and medical devices that are embodiments of the invention. The description and drawings are exemplary in nature and are provided to enable one skilled in the art to make and use one or more support frames or medical devices as an embodiment of the invention. The description and drawings are not intended to limit the scope of the claims in any manner.
Inventive intraluminal support frames and medical devices are described. The support frames are useful in the making of intraluminal medical devices, including the medical devices described herein. The support frames may also be useful as medical devices themselves, such as intraluminal stents. The medical devices can be used in any suitable intraluminal environment and to achieve any desired treatment effect in an animal, including human and non-human animals. For example, some of the example medical devices are useful for regulating fluid flow through a body vessel of a patient. As such, the medical devices can be used as valve devices. The medical devices also may be useful for other intraluminal purposes.
Support Frames
The support frame 100 is an expandable support frame comprising proximal 102 and distal 104 portions connected by various connector segments 106, 108, 110, 112. The proximal portion 102 defines a first serpentine path 114 that extends around the circumference of the support frame 100. The distal portion 104 defines a second serpentine path 116 that also extends around the circumference of the support frame 100. The first serpentine path 114 includes pairs of straight strut portions 118 and bends 120, each of which is disposed between and connected to a circumferentially adjacent pair of the connector segments 106, 108, 110, 112. The second serpentine path 116 includes curvilinear struts 122, 124, 126, 128. Similar to the first serpentine path 114, each of the curvilinear struts 122, 124, 126, 128 is disposed between and connected to a circumferentially adjacent pair of the connector segments 106, 108, 110, 112. Thus, each serpentine path 114, 116 is joined to connector segments 106, 108, 110, 112.
In the illustrated embodiment, each of the connector segments 106, 108, 110, 112 includes first and second straight struts, designated by the corresponding reference number along with a or b, e.g., 110a, 110b, that are disposed parallel to each other. For each of the connector segments 106, 108, 110, 112, the straight struts are connected to each other by to curvilinear struts, designated by the corresponding reference number along with c or d, e.g., 110c, 110d. This arrangement of struts in the connector segments 106, 108, 110, 112 is considered advantageous at least because it provides a degree of structural redundancy and gives a secondary attachment point for associated materials and/or components in medical devices that include the support frame 100. In the illustrated embodiment, each of connector segments 106, 108, 110, 112 is disposed substantially on the circumferential plane of the support frame 100. It is noted, though, that one or more of the connector segments in a support frame according to a particular embodiment can be disposed entirely or partially outside of the circumferential plane of the support frame 100. For example, one or more connector segments may include a bend or curve that projects outwardly with respect to a longitudinal axis of the support frame. Connector segments with these structural features may be advantageous when additional surface area for contact with a wall of a body vessel and/or formation of an artificial sinus is desired, for example.
The support frame 100 illustrated in
While the support frame 100 illustrated in
In the illustrated embodiment, each of the curvilinear struts 122, 124, 126, 128 extends between and joins two of the connector segments 106, 108, 110, 112. For example, as best illustrated in
Inclusion of the curvilinear struts at only the distal end 104 of the support frame 100 provides directionality to the structure of the support frame 100, which is considered advantageous at least because it facilitates fabrication of medical devices that include the support frame 100. It is noted, though, that one or more curvilinear struts can be included on the proximal end, or at any other desirable location, of a support frame according to a particular embodiment.
Each curvilinear strut 122, 124, 126, 128 can have any suitable curvilinear configuration. A skilled artisan will be able to determine an appropriate configuration for a support frame according to a particular embodiment based on various considerations, including the nature of the body vessel within which the support frame is intended to be used, and the nature, size and configuration of any materials and/or additional elements that are attached to the support frame in the fabrication of a medical device that includes the support frame. Examples of suitable curvilinear configurations include curvilinear forms that define arcs, circular arcs, great arcs, s-curves, and others. Furthermore, in any particular embodiment, each curvilinear strut, if multiple curvilinear struts are included, can have the same or different curvilinear configuration as another of the curvilinear struts in the support frame. In the illustrated example embodiment, each of the curvilinear struts has the same curvilinear configuration. While considered advantageous for this illustrated example, this is merely an example of a suitable configuration and arrangement.
The inventors have determined that curvilinear struts that define circular arcs are particularly advantageous for inclusion in the support frames described herein. For example, each of the curvilinear struts 122, 124, 126, 128 in the embodiment illustrated in
For a curvilinear strut that defines an arc that is a circular arc or great arc, the arc can comprise a segment of the circumference of any suitable circle. As a result, the arc can have any suitable radius of curvature. A skilled artisan will be able to select an appropriate radius of curvature for such an arc for a support frame according to a particular embodiment based on various considerations, such as the nature and size of the body vessel within which the support frame is to be implanted, the number of curvilinear struts included in the support frame, and the nature, size and/or configuration of any additional material or elements included in a medical device within which the support frame is used.
The inventors have determined that a radius of curvature that is based on the radius of the circumference of the support frame in its expanded configuration provides desirable structural properties. For these structural measurements, the circumference of the support frame is a circumference of a transverse cross-section of the support frame with respect to the longitudinal axis of the support frame. The radius can be measured to either an inner or an outer circumferential surface, or a hypothetical circumferential surface by extension of an actual surface, of the support frame. For example, inclusion of one or more curvilinear struts that define an arc having a radius of curvature that is between about 1/16th the radius of the circumference of the support frame in its expanded configuration and about 1× the radius of the circumference of the support frame in its expanded configuration is suitable. Additional examples of suitable radii of curvature for curvilinear struts include radii of curvature between about ⅛th the radius of the circumference of the support frame in its expanded configuration and about 1× the radius of the circumference of the support frame in its expanded configuration is suitable, radii of curvature between about ¼th and about ¾th the radius of the circumference of the support frame in its expanded configuration, and a radius that is about ½ the radius of the circumference of the support frame in its expanded configuration.
In the embodiment illustrated in
In the illustrated embodiment, support frame 100 includes first 140 and second 142 support struts, each of which extends between and is connected to two of the curvilinear struts 122, 124, 126, 128. While considered optional, the inclusion of support struts 140, 142 may provide desirable structural properties for support frames and/or medical devices according to particular embodiments. If included, the support struts can have any suitable size and configuration. For example, the support struts can comprise straight struts or curvilinear struts. As illustrated in
In all embodiments, the support frame advantageously comprises an expandable support frame having radially compressed and radially expanded configurations. Such a support frame can be implanted at a point of treatment within a body vessel by minimally invasive techniques, such as delivery and deployment with a catheter sized and conFIG.d for navigation within the body vessel. It is noted, though, that support frames and medical devices according to embodiments of the invention, regardless of the type and/or nature of the support frame, can be implanted by other techniques, including surgical techniques.
In all embodiments, the support frame can provide a stenting function, i.e., exert a radially outward force on the interior wall of a vessel in which the support frame, or medical device including the support frame, is implanted. By including a support frame that exerts such a force, a medical device according to the invention can provide multiple functions, such as a stenting and a valving function, at a point of treatment within a body vessel, which may be desirable in certain situations, such as when a degree of vessel stenosis, occlusion, and/or weakening is present.
Support frames according to particular embodiments can include additional structural elements, such as additional struts and bends. The inclusion of additional struts and/or bends may be desirable, for example, in support frames and medical devices intended for implantation at locations in the body where lower radial force on the tissue is desired. For these embodiments, the inclusion of additional struts and/or bends can distribute the radial force of the support frame across more structural elements, thereby reducing the radial force exerted by a particular portion of the support frame against tissue at a point of treatment. A support frame according to an embodiment can include conventional structural features that facilitate anchoring of the support frame at a point of treatment within a body vessel, such as barbs and/or microbarbs, and structural features, such as radiopaque markers, that facilitate visualization of the support frame in conventional or other medical visualization techniques, such as radiography, fluoroscopy, and other techniques. Furthermore, a support frame according to an embodiment can include structural features, such as eyelets, barbs, fillets and other suitable structures, that provide attachment points for grafts and other materials.
In all embodiments, the support frame can be self-expandable or can require an input of force to affect expansion, such as a balloon expandable support frame. Each type of support frame has advantages and for any given application, one type may be more desirable than other types based on a variety of considerations. For example, in the peripheral vasculature, vessels are generally more compliant and typically experience dramatic changes in their cross-sectional shape during routine activity. Support frames and medical devices for implantation in the peripheral vasculature should retain a degree of flexibility to accommodate these changes of the vasculature. Accordingly, support frames and medical devices according to the invention intended for implantation in the peripheral vasculature, such as valve devices, advantageously include a self-expandable support frame.
In all embodiments, the support frames can be made from any suitable material and a skilled artisan will be able to select an appropriate material for use in a support frame according to a particular embodiment based on various considerations, including any desired flexibility and visualization characteristics. The material selected for a support frame according to a particular embodiment need only be biocompatible or be able to be made biocompatible. Examples of suitable materials include, without limitation, stainless steel, nickel titanium (NiTi) alloys, e.g., Nitinol, other shape memory and/or superelastic materials, molybdenum alloys, tantalum alloys, titanium alloys, precious metal alloys, nickel chromium alloys, cobalt chromium alloys, nickel cobalt chromium alloys, nickel cobalt chromium molybdenum alloys, nickel titanium chromium alloys, linear elastic Nitinol wires, polymeric materials, and composite materials. Also, absorbable and bioremodellable materials can be used. As used herein, the term “absorbable” refers to the ability of a material to degrade and to be absorbed into a tissue and/or body fluid upon contact with the tissue and/or body fluid. A number of absorbable materials are known in the art, and any suitable absorbable material can be used. Examples of suitable types of absorbable materials include absorbable homopolymers, copolymers, or blends of absorbable polymers. Specific examples of suitable absorbable materials include poly-alpha hydroxy acids such as polylactic acid, polylactide, polyglycolic acid (PGA), or polyglycolide; trimethlyene carbonate; polycaprolactone; poly-beta hydroxy acids such as polyhydroxybutyrate or polyhydroxyvalerate; or other polymers such as polyphosphazines, polyorganophosphazines, polyanhydrides, polyesteramides, polyorthoesters, polyethylene oxide, polyester-ethers (e.g., polydioxanone) or polyamino acids (e.g., poly-L-glutamic acid or poly-L-lysine). There are also a number of naturally derived absorbable polymers that may be suitable, including modified polysaccharides, such as cellulose, chitin, and dextran, and modified proteins, such as fibrin and casein.
Stainless steel and nitinol are currently considered desirable materials for use in the support frame due at least to their biocompatibility, shapeability, and well-characterized nature. Also, cold drawn cobalt chromium alloys, such as ASTM F562 and ASTM F1058 (commercial examples of which include MP35N™ and Elgiloy™, both of which are available from Fort Wayne Metals, Fort Wayne, Ind.; MP35N is a registered trademark of SPS Technologies, Inc. Jenkintown, Pa., USA); Elgiloy is a registered trademark of Combined Metals of Chicago LLC (Elk Grove Village, Ill., USA)), are currently considered advantageous materials for the support frames at least because they are non-magnetic materials that provide beneficial magnetic resonance imaging (MRI) compatibility and avoid MRI artifacts typically associated with some other materials, such as stainless steel.
The support frames can be fabricated in any suitable manner and by any suitable technique. Skilled artisans will be able to select an appropriate manner and/or technique for fabricating a support frame according to a particular embodiment based on various considerations, including the nature of the material from which the support frame is being fabricated. Examples of suitable techniques include forming the support frame from wire, such as by wrapping a suitable wire around a suitable mandrel, by cutting the support frame from a tubular section of an appropriate material, such as by laser-cutting the support frame from a metal tubular member, and by forming the desired structure of the support frame in sheet form, such as by vapor deposition or other suitable technique, configuring the sheet into tubular form, such as by rolling or other suitable technique, and fixing the support frame in tubular form, such as by laser-welding or other suitable technique.
The support frame 200 of this embodiment is similar to support frame 100 illustrated in
Similar to the first exemplary embodiment, connector segments 206 and 208 are disposed substantially opposite each other with respect to longitudinal axis a1, and connector segments 210 and 212 are disposed substantially opposite each other with respect to longitudinal axis a1. The support frame 200 includes only two connector segments 210, 212 that each include first and second struts, designated by the corresponding reference number along with a or b, e.g., 210a, 210b. Remaining connector segments 206, 208 each include only a single strut. This configuration is considered advantageous for support frames and medical devices in which a reduction in the overall amount of surface area of the support frame is desirable.
Also, the first 210a and second 210b struts of the first connector segment 210 are disposed at a slight angle with respect to each other and longitudinal axis a1, placing the struts 210a, 210b in a skewed arrangement with respect to each other. A parallel or substantially parallel arrangement of the struts that comprise a particular connector segment is considered advantageous, but a skewed arrangement, such as the arrangement illustrated in
While the example support frame 200 includes four eyelets 250a, 250b, 252a, 252b, any suitable number of eyelets can be included in a support frame according to a particular embodiment. Furthermore, the each of the eyelets included in a support frame according to a particular embodiment can be placed at any suitable position on the connector segments for that support frame. Furthermore, the eyelet or eyelet on one straight strut in a connector segment can be positioned at the same or different position, relative to the height of the respective connector segment, as the eyelet or eyelets on another straight strut in a connector segment. A skilled artisan will be able to select an appropriate number of eyelets, an appropriate position for the eyelet or eyelets on the struts of a connector segment, and the relative distribution of the eyelet or eyelets on the straight struts of a connector segment in a support frame according to a particular embodiment based on various considerations, including any desired attachment points for an additional element, such as a graft or leaflet, that will be attached to the support frame, such as in the making of a medical device.
Also in this embodiment, the support frame 200 includes centering struts 244, 246, each of which extends in a proximal and radially outward direction from one of the straight strut portions 218 of the first serpentine path 214. The inventors have determined that the inclusion of centering struts 244, 246 provides beneficial deployment and positioning properties. For example, upon deployment in a body vessel, centering struts 244, 246 provide additional contact with the wall of the body vessel at the proximal portion 202 of the support frame 200, which can prevent or minimize tilting of the support frame 200 with respect to the longitudinal axes of the support frame 200 and the body vessel. If included, the centering struts can have any suitable size and configuration. For example, the centering struts can comprise straight struts, angled struts, a combination of straight struts and bends, as in the illustrated embodiment, or additional curvilinear struts. These struts, if included, can also provide a desirable location for placement of visualization makers, either as a structure fully or partially formed by these struts or as a structure attached to these struts.
In this embodiment, a series of connector struts 260, 262, 264, 266 extend between and join pairs of the connector segments 206, 208, 210, 212. Each of the connector struts 260, 262, 264, 266 extends between one of the connector segments 210, 212 that includes two struts, such as struts 210a and 210b, and one of the connector segments that includes only a single strut, such as connector segment 208. Thus, for example, connector strut 260 extends between and joins connector segments 210 and 206. Similarly, connector strut 262 extends between and joins connector segments 210 and 208.
Each of the connector struts 260, 262, 264, 266 lies on a plane that is disposed at an angle γ to a plane t1 that orthogonally transects the longitudinal axis a1 and includes the terminal structures of the distal portion 204 of the support frame 200. Each connector strut 260, 262, 264, 266 can lie on a plane disposed at any suitable angle. A skilled artisan will be able to determine an appropriate angle for each connector strut in a support frame according to a particular embodiment based on various considerations, including the nature of the body vessel within which the support frame is intended to be used, and the nature, size and configuration of any materials and/or additional elements that are attached to the support frame in the fabrication of a medical device that includes the support frame. Examples of suitable angles include angles between about 30° and about 50°, angles between about 30° and about 40°, and an angle that is about 35°.
While each of the connector struts 260, 262, 264, 266 in the illustrated embodiment is disposed at the same or substantially the same angle γ when the support frame is in its expanded configuration, different angles can be used for some or all of the connector struts. While considered advantageous, the illustrated configuration is merely an example of a suitable configuration.
The support frame 300 of this embodiment is similar to support frame 200 illustrated in
Connector segments 306 and 308 are disposed substantially opposite each other with respect to longitudinal axis a1, and connector segments 310 and 312 are disposed substantially opposite each other with respect to longitudinal axis a1. Similar to the embodiment illustrated in
In this embodiment, the pair of struts that define each of connector segments 310 and 312 are disposed substantially parallel to each other. Also, each of the struts in the pair of struts that define each of connector segments 310 and 312 defines a single eyelet. Thus, as best illustrated in
In this embodiment, a series of connector struts 360, 362, 364, 366 extend between and join pairs of the connector segments 306, 308, 310, 312. Each of the connector struts 360, 362, 364, 366 extends between one of the connector segments 310, 312 that includes two struts, such as struts 310a and 310b, and one of the connector segments that includes only a single strut, such as connector segment 308. Thus, for example, connector strut 360 extends between and joins connector segments 310 and 306. Similarly, connector strut 362 extends between and joins connector segments 310 and 308.
In this embodiment, each of the connector struts 360, 362, 364, 366 is a curvilinear strut that includes a straight portion, designated by the corresponding reference number along with a. The straight portion 360a, 362a, 364a, 366a of each of the connector struts 360, 362, 364, 366 lies on a plane that is disposed at an angle γ to a plane that orthogonally transects the longitudinal axis a1 and includes the terminal structures of the distal portion 304 of the support frame 300. Each connector strut 360, 362, 364, 366 can lie on a plane disposed with its respective straight portion 360a, 362a, 364a, 366a at any suitable angle. A skilled artisan will be able to determine an appropriate angle for each connector strut in a support frame according to a particular embodiment based on various considerations, including the nature of the body vessel within which the support frame is intended to be used, and the nature, size and configuration of any materials and/or additional elements that are attached to the support frame in the fabrication of a medical device that includes the support frame. Examples of suitable angles include angles between about 30° and about 50°, angles between about 30° and about 40°, and an angle that is about 35°.
While each of the connector struts 360, 362, 364, 366 in the illustrated embodiment is disposed with the respective straight portion 360a, 362a, 364a, 366a at the same or substantially the same angle γ when the support frame is in its expanded configuration, different angles can be used for some or all of the connector struts. While considered advantageous, the illustrated configuration is merely an example of a suitable configuration.
Each of
If included, the bars 350′, 352′ can be positioned in a similar manner as the eyelets 350, 352 in the support frame 300 illustrated in
Inclusion of additional bars is optional. If included, any additional bars can be positioned at any suitable location on the connector segment 310′.
In
Medical Devices
The medical device 400 is a valve device that includes the first example support frame 100 illustrated in
The medical device 400 is a valve device that is useful for regulating fluid flow through a body vessel. Each of the leaflets 480, 482 is movable between first and second positions. In the first position, the orifice 488 is open and allows fluid flow through the device 400 in a first direction. In the second position, the free edges 484, 486 of leaflets 480, 482 come together to close the orifice 488 and substantially prevent fluid flow through the device 400 in a second, opposite direction.
Each of the leaflets 480, 482 can have any suitable size, shape and/or configuration. A skilled artisan will be able to select leaflets having appropriate size, shape and configuration properties for a medical device according to a particular embodiment based on various considerations, including any desired performance characteristics of the medical device. The inventors have determined that leaflets that, when attached to a support frame and when the support frame is in an expanded configuration and the leaflets subjected to fluid pressure sufficient to effect closure of the valve orifice, define a domed radius of curvature, i.e., a portion of one surface of the leaflet lies on a portion of a spherical plane or substantially spherical plane, provide desirable performance characteristics for medical devices intended to be used as valve devices, such as prosthetic venous valve devices. In these embodiments, the portion of a spherical plane or substantially spherical plane can comprise a portion of the spherical plane of any suitable sphere. As a result, the portion of a spherical plane or substantially spherical plane can have any suitable radius of curvature. Also in these embodiments, the portion the surface of the leaflet that defines the domed radius can comprise any suitable portion of the leaflet surface, including a central portion that does not contact any struts or other structural members of the associated support frame, a base portion that is positioned at the bottom of a valve pocket formed in the valve device when the valve orifice is closed, or any other suitable portion of the leaflet surface. A skilled artisan will be able to select an appropriate portion of the leaflet surface and an appropriate radius of curvature for a medical device according to a particular embodiment based on various considerations, including the nature and size of the body vessel within which the medical device is to be implanted, and the nature of the material from which the leaflets are formed. Also, it is noted that the domed radii described herein are present in the respective leaflet at least when the leaflet is subjected to fluid pressure sufficient to close the associated valve orifice, such as when the medical device containing the leaflet is exposed to such fluid pressure in vivo or in suitable testing environments, such as in a vessel simulator or a simple fluid container.
The inventors have determined that leaflets defining a domed radius that is based on the radius of the circumference of the support frame in its expanded configuration provides desirable structural properties. For example, inclusion of one or more curvilinear leaflets that define a domed radius having a radius of curvature that is between about ⅛th the radius of the circumference of the support frame in its expanded configuration and about 1× the radius of the circumference of the support frame in its expanded configuration is suitable. Additional examples of suitable radii of curvature include radii of curvature between about ¼th and about ¾th the radius of the circumference of the support frame in its expanded configuration, and a radius that is about ½ the radius of the circumference of the support frame in its expanded configuration.
The exemplary medical device 400 is illustrated with the support frame 100 in an expanded configuration and with the leaflets 480, 482 in the configuration they adopt when subjected to fluid pressure sufficient to effect closure of the valve orifice. As illustrated in the FIG., in this state, each of the leaflets 480, 482 defines a domed radius of curvature r that is about ½ the radius R of the circumference of the support frame 100 in its expanded configuration. The inventors have determined that this configuration of the leaflets 480, 482 is advantageous at least because of the beneficial performance characteristics provided by the arrangement.
It is noted that, while the medical device 400 is illustrated as including support frame 100, any suitable support frame that positions the leaflets 480, 482 in the desired configuration, i.e., with the domed radius, can be used. For example, leaflets can be attached to any of the support frame described and illustrated herein such that the desired configuration is achieved. A skilled artisan will be able to select an appropriate support frame for a medical device according to a particular embodiment based on various considerations, including the nature, size and configuration of the material forming the leaflets.
The medical device 500 is a valve device that includes the third exemplary support frame 300 illustrated in
The medical device 500 is a valve device that is useful for regulating fluid flow through a body vessel. Each of the leaflets 580, 582 is movable between first and second positions. In the first position, the orifice 588 is open and allows fluid flow through the device 500 in a first direction. In the second position, the free edges 584, 586 of leaflets 580, 582 come together to close the orifice 588 and substantially prevent fluid flow through the device 500 in a second, opposite direction.
In this embodiment, each attachment pathway 370, 372 extends along a portion of the axial length of connector segment 310 and along a portion of the axial length of connector segment 312. For each attachment pathway 370, 372 and each connector segment 310, 312, the portion of the axial length of the connector segment 310, 312 along which the attachment pathway extends can be any suitable portion of the axial length of the connector segment 310, 312, including the entire axial length of the connector segment 310, 312. For each attachment pathway and each connector segment in a medical device according to a particular embodiment, a skilled artisan will be able to select an appropriate portion of the axial length along which the attachment pathway extends based on various considerations, such as the nature, size and configuration of the leaflets or other material and/or additional elements included in the medical device.
The inventors have determined that a portion of the axial length of the connector segment along which the attachment pathway extends that is between about 1/16th the full axial length of the connector segment and about the full axial length of the connector segment is suitable. Additional examples of suitable portions of the axial length of the connector segments along which the attachment pathways extend include portions of the axial length of the connector segments that are between about ⅛th the full axial length of the connector segment and about ¾th the full axial length of the connector segment, and portions of the axial length of the connector segments that are between about ¼th the full axial length of the connector segment and about ½ the full axial length of the connector segment.
In the embodiment illustrated in
In any particular embodiment, the attachment pathways, if included, can extend along the same or different portion of the axial length of each connector segment. For example, a medical device according to an embodiment can include a first attachment pathway that extends along approximately equal portions of the axial lengths of first and second connector segments and a second attachment pathway that extends along approximately equal portions of the axial lengths of the first and second connector segments that are different than the portions along which the first attachment pathway extends. Furthermore, a medical device according to an embodiment may include one or more attachment pathways that extends along a portion of the axial length of a first connector segment and along a portion of the axial length of a second connector segment that is less than, equal to, approximately equal to, or greater than the portion of the axial length of the first connector segment.
In the illustrated embodiment, the attachment pathways 370, 372 also extend along connector struts 360, 362, 364, 366 that extend between and join adjacent pairs of connector segments 306, 308, 310, 312. If included, any suitable connector struts can be used in a medical device according to a particular embodiment and a skilled artisan will be able to select appropriate connector struts based on various considerations, including the nature of the material from which the element(s) being attached to the support frame, such as leaflets, is formed. As illustrated in
The medical device 600 is a valve device that includes a modified version of the third exemplary support frame 300′ illustrated in
The medical device 600 is a valve device that is useful for regulating fluid flow through a body vessel. Each of the leaflets 680, 682 is movable between first and second positions. In the first position, the orifice 688 is open and allows fluid flow through the device 600 in a first direction. In the second position, the free edges 684, 686 of leaflets 680, 682 come together to close the orifice 688 and substantially prevent fluid flow through the device 600 in a second, opposite direction.
In this embodiment, support frame 300 includes eyelets 350′, 352′, 354′, 356′. The first 310a′ strut of the first connector segment 310′ defines eyelet 350′. Similarly, the second strut 310b′ of the first connector segment 310′ defines eyelet 354′. Similarly, the first 312a′ and second 312b′ struts of the second connector segment each defines one of remaining eyelets 354′, 356′. Each of the eyelets is a ring-shaped structure defining an opening. As best illustrated in
In this embodiment, the free edge 684, 686 of each leaflet defines a curve. If leaflets having this structure are included, any suitable curve can be used and a skilled artisan will be able to select an appropriate curve or curves based on various considerations, including the nature of the material from which the leaflets are formed. As best illustrated in
If a leaflet having a free edge defining a curve is used, the curve can be formed prior to attaching the leaflet to the support frame, or can be formed following attachment of the leaflet to the support frame, such as by cutting the leaflet to create a free edge defining a desired curve.
In all embodiments, any suitable materials and/or additional elements can be attached to the support frame to form a medical device. A skilled artisan will be able to select an appropriate material for use with a support frame in a medical device according to a particular embodiment based on various considerations, including the intended use and desired function of the medical device. For valve devices, such as the valve device illustrated in
Any attached materials can have any suitable size, shape and configuration. For example, valve devices can include one, two or more leaflets that are sheet-like sections of material attached to a support frame according to an embodiment. Another example of a material that can be attached to a support frame according to an embodiment is a tubular structure that is attached around the outer circumference of the support frame. Indeed, a tubular structure and one, two or more leaflets can be attached to a support frame according to an embodiment to form a valve device having an outer sleeve.
In all embodiments including additional material and/or elements attached to the support frame, the additional material and/or elements can be attached to the support frame in any suitable manner and with any suitable structure and/or substance. For example, leaflets can be attached to a support frame in a valve device using sutures, tissue welding, adhesive(s), mechanical attachment(s), a combination of these approaches, and any other suitable structure and/or substance.
In all embodiments including an additional material and/or elements attached to the support frame, the additional material and/or elements can be attached to the support frame in any suitable orientation. A skilled artisan will be able to select a suitable orientation for a particular material or element attached to the support frame in a specific embodiment based on various considerations, including the physical properties of the material or element and any desired properties of the resulting medical device that may be impacted by the orientation of the material or element. For example, for valve devices that include one or more leaflets attached to the support frame, it may be desirable to attach the leaflet or leaflets in a particular orientation based on the ability of the leaflet to stretch in a particular direction. Anisotropic materials may be able to stretch to a greater degree along one axis than along another axis. The inventors have determined that, when attaching an anisotropic material to a support frame to form a medical device, it may be desirable to attach the material in an orientation in which the axis along which the material has a greater ability to stretch is aligned with the longitudinal axis of the support frame if it is desirable to have the leaflet of the medical device form a relatively deeper valve pocket when the medical device is subjected to sufficient fluid pressure to move the leaflet to a closed position. Conversely, the inventors have determined that it may be desirable to attach the material in an orientation in which the axis along which the material has a greater ability to stretch is aligned in a transverse orientation to the longitudinal axis of the support frame if it is desirable to have the leaflet of the medical device form a relatively larger valve orifice when the medical device is subjected to sufficient fluid pressure to move the leaflet to an open position.
For valve devices, the inventors have determined that attaching a leaflet to a support frame described herein while the leaflet is held in an open position can provide desirable performance characteristics to the resulting valve device. Specifically, the inventors have determined that attaching a leaflet to a support frame described herein while the leaflet is held in an open position on a mandrel such that a degree of slack is provided in a portion of the leaflet that will have a domed radius can provide desirable performance characteristics to the resulting valve device.
Furthermore, while the medical devices described and illustrated herein are valve devices, it is noted that other types of medical devices can be made in accordance with the disclosure. For example, a vessel occluder can include a support frame according to an embodiment along with leaflets that are sewn or otherwise attached to each other to permanently close an associated valve orifice or a graft material that lacks an orifice.
The support frames and medical devices can be implanted within a body vessel at a desired point of treatment using conventional minimally-invasive techniques, such as by delivery with an associated catheter, by surgical techniques, or by any other suitable technique for placing a support frame or medical device at a point of treatment within a body vessel.
The foregoing detailed description refers to example support frames and medical devices and includes the best mode for practicing the invention. The description and the appended drawings illustrating the described devices are intended only to provide examples and not to limit the scope of the claims in any manner.
This application is a continuation of U.S. patent application Ser. No. 14/176,364, filed on Feb. 10, 2014, and which claims the benefit of U.S. Provisional Application No. 61/763,107, filed on Feb. 11, 2013. The entire contents of each of these related applications is incorporated into this disclosure by reference.
Number | Name | Date | Kind |
---|---|---|---|
3012882 | Muldawer et al. | Dec 1961 | A |
3014104 | Cobine et al. | Dec 1961 | A |
3174851 | Buehler et al. | Dec 1961 | A |
3063967 | Schultz | Nov 1962 | A |
3169945 | Hostettler et al. | Feb 1965 | A |
3391126 | Baggett et al. | Jul 1968 | A |
3464065 | Cromie | Sep 1969 | A |
3583391 | Cox et al. | Jun 1971 | A |
3589392 | Meyer | Jun 1971 | A |
3645941 | Snapp et al. | Feb 1972 | A |
3710744 | Goodenough et al. | Jan 1973 | A |
3736598 | Bellhouse et al. | Jun 1973 | A |
3737919 | Child | Jun 1973 | A |
3772137 | Tolliver | Nov 1973 | A |
3912692 | Casey et al. | Oct 1975 | A |
3942532 | Hunter et al. | Mar 1976 | A |
3953566 | Gore | Apr 1976 | A |
3983581 | Angell et al. | Oct 1976 | A |
4052988 | Doddi et al. | Oct 1977 | A |
4076807 | Trinh et al. | Feb 1978 | A |
4093061 | Horak | Jun 1978 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4218782 | Rygg | Aug 1980 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4243775 | Rosensaft et al. | Jan 1981 | A |
4274292 | Angell | Jan 1981 | A |
4272854 | Bokros | Jun 1981 | A |
4275469 | Gabbay | Jun 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
4300565 | Rosensaft et al. | Nov 1981 | A |
4328592 | Klawitter | May 1982 | A |
4340977 | Brownlee et al. | Jul 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4350492 | Wright et al. | Sep 1982 | A |
4364126 | Rosen | Dec 1982 | A |
4429080 | Casey et al. | Jan 1984 | A |
4440789 | Mattei et al. | Apr 1984 | A |
4441216 | Ionescu et al. | Apr 1984 | A |
4470157 | Love | Sep 1984 | A |
4494531 | Gianturco | Jan 1985 | A |
4506394 | Bedard | Mar 1985 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4549921 | Wolfe, Jr. | Oct 1985 | A |
4559945 | Koelmel et al. | Dec 1985 | A |
4564014 | Fogarty | Jan 1986 | A |
4580568 | Gianturco | Apr 1986 | A |
4591630 | Gertzman et al. | May 1986 | A |
4605730 | Shalaby et al. | Aug 1986 | A |
4624256 | Messier et al. | Nov 1986 | A |
4643732 | Pietsch et al. | Feb 1987 | A |
4643734 | Lin | Feb 1987 | A |
4653497 | Bezwada et al. | Mar 1987 | A |
4657024 | Coneys | Apr 1987 | A |
4661300 | Daugherty | Apr 1987 | A |
4665906 | Jervis | May 1987 | A |
4665918 | Garza et al. | May 1987 | A |
4666442 | Arru et al. | May 1987 | A |
4675361 | Ward et al. | Jun 1987 | A |
4692164 | Dzemeshkevich | Sep 1987 | A |
4700704 | Jamiolkowski et al. | Oct 1987 | A |
4731074 | Rousseau et al. | Mar 1988 | A |
4731075 | Gallo Mezo et al. | Mar 1988 | A |
4755593 | Lauren | Jul 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4762129 | Bonzel | Aug 1988 | A |
4776337 | Palmaz | Oct 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4788979 | Jarrett et al. | Dec 1988 | A |
4791929 | Jarrett et al. | Dec 1988 | A |
4798611 | Freeman | Jan 1989 | A |
4800603 | Jaffe | Jan 1989 | A |
4806595 | Noishiki et al. | Feb 1989 | A |
4816028 | Kapadia | Mar 1989 | A |
4816029 | Penny et al. | Mar 1989 | A |
4832055 | Palestrant | May 1989 | A |
4836204 | Landymore et al. | Jun 1989 | A |
4838267 | Jamiolkowski et al. | Jun 1989 | A |
4851000 | Gupta | Jul 1989 | A |
4856510 | Kowalewski | Aug 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4861830 | Ward et al. | Aug 1989 | A |
4872875 | Hwang | Oct 1989 | A |
4893623 | Rosenbluth | Jan 1990 | A |
4902508 | Badylak et al. | Feb 1990 | A |
4911163 | Fina | Mar 1990 | A |
4917089 | Sideris | Apr 1990 | A |
4923465 | Knock et al. | May 1990 | A |
4952215 | Ouriel et al. | Aug 1990 | A |
4956178 | Badylak et al. | Sep 1990 | A |
4969458 | Wiktor | Nov 1990 | A |
4992027 | Acosta | Feb 1991 | A |
4994071 | MacGregor | Feb 1991 | A |
4994074 | Bezwada et al. | Feb 1991 | A |
4994077 | Dobben | Feb 1991 | A |
5007923 | Bezwada et al. | Apr 1991 | A |
5017664 | Grasel et al. | May 1991 | A |
5019085 | Hillstead | May 1991 | A |
5020612 | Williams | Jun 1991 | A |
5024671 | Tu et al. | Jun 1991 | A |
5024841 | Chu et al. | Jun 1991 | A |
5035706 | Gianturco et al. | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5041126 | Gianturco | Aug 1991 | A |
5047048 | Bezwada et al. | Sep 1991 | A |
5053008 | Bajaj | Oct 1991 | A |
5067491 | Taylor, II et al. | Nov 1991 | A |
5076807 | Bezwada et al. | Dec 1991 | A |
5080665 | Jarrett et al. | Jan 1992 | A |
5080670 | Imamura et al. | Jan 1992 | A |
5085629 | Goldberg et al. | Feb 1992 | A |
5100433 | Bezwada et al. | Mar 1992 | A |
5103817 | Reisdorf et al. | Apr 1992 | A |
5104402 | Melbin | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5108420 | Marks | Apr 1992 | A |
5108425 | Hwang | Apr 1992 | A |
5110064 | Kimura et al. | May 1992 | A |
5116365 | Hillstead | May 1992 | A |
5116564 | Jansen et al. | May 1992 | A |
5133725 | Quadri | Jul 1992 | A |
5133755 | Brekke | Jul 1992 | A |
5139515 | Robicsek | Aug 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5171259 | Inoue | Dec 1992 | A |
5174295 | Christian et al. | Dec 1992 | A |
5176692 | Wilk et al. | Jan 1993 | A |
5178618 | Kandarpa | Jan 1993 | A |
5178632 | Hanson | Jan 1993 | A |
5178633 | Peters | Jan 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5192313 | Budd et al. | Mar 1993 | A |
5197979 | Quintero et al. | Mar 1993 | A |
5197980 | Gorshkov | Mar 1993 | A |
5201314 | Bosley et al. | Apr 1993 | A |
5201757 | Heyn et al. | Apr 1993 | A |
5226889 | Sheiban | Jul 1993 | A |
5234457 | Andersen | Aug 1993 | A |
5239982 | Trauthen | Aug 1993 | A |
5258000 | Gianturco | Nov 1993 | A |
5275826 | Badylak et al. | Jan 1994 | A |
5281422 | Badylak et al. | Jan 1994 | A |
5282824 | Gianturco | Feb 1994 | A |
5284488 | Sideris | Feb 1994 | A |
5289831 | Bosley | Mar 1994 | A |
5293879 | Vonk et al. | Mar 1994 | A |
5306294 | Winston et al. | Apr 1994 | A |
5314444 | Gianturco | May 1994 | A |
5314472 | Fontaine | May 1994 | A |
5314473 | Godin | May 1994 | A |
5322062 | Servas | Jun 1994 | A |
5327891 | Rammler | Jul 1994 | A |
5334210 | Gianturco | Aug 1994 | A |
5334217 | Das | Aug 1994 | A |
5342387 | Summers | Aug 1994 | A |
5344426 | Lau et al. | Sep 1994 | A |
5352240 | Ross | Oct 1994 | A |
5358518 | Camilli | Oct 1994 | A |
5366473 | Winston et al. | Nov 1994 | A |
5366479 | McGarry et al. | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5376113 | Jansen et al. | Dec 1994 | A |
5380320 | Morris | Jan 1995 | A |
5383892 | Cardon et al. | Jan 1995 | A |
5387235 | Chuter | Feb 1995 | A |
5389106 | Tower | Feb 1995 | A |
5393594 | Koyfman et al. | Feb 1995 | A |
5397311 | Walker | Mar 1995 | A |
5397331 | Himpens et al. | Mar 1995 | A |
5397355 | Marin et al. | Mar 1995 | A |
5405377 | Cragg | Apr 1995 | A |
5405381 | Olin | Apr 1995 | A |
5411552 | Andersen | May 1995 | A |
5412068 | Tang et al. | May 1995 | A |
5413599 | Imachi et al. | May 1995 | A |
5417708 | Hall et al. | May 1995 | A |
5421955 | Lau et al. | Jun 1995 | A |
5425744 | Fagan et al. | Jun 1995 | A |
5433727 | Sideris | Jul 1995 | A |
5441515 | Khosravi et al. | Aug 1995 | A |
5443496 | Schwartz | Aug 1995 | A |
5449373 | Pinchasik | Sep 1995 | A |
5451235 | Lock et al. | Sep 1995 | A |
5456713 | Chuter | Oct 1995 | A |
5468253 | Bezwada et al. | Nov 1995 | A |
5486193 | Bourne | Jan 1996 | A |
5486195 | Myers et al. | Jan 1996 | A |
5489297 | Duran | Feb 1996 | A |
5500014 | Quijano | Mar 1996 | A |
5507767 | Maeda et al. | Apr 1996 | A |
5507771 | Gianturco | Apr 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5522841 | Roby et al. | Jun 1996 | A |
5527354 | Fontaine et al. | Jun 1996 | A |
5530683 | Lindberg | Jun 1996 | A |
5540712 | Kleshinski et al. | Jul 1996 | A |
5540713 | Schnepp-Pesch et al. | Jul 1996 | A |
5545215 | Duran | Aug 1996 | A |
5549662 | Fordenbacher | Aug 1996 | A |
5549663 | Cottone, Jr. | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5554119 | Harrison et al. | Sep 1996 | A |
5554181 | Das | Sep 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5554389 | Badylak et al. | Sep 1996 | A |
5562728 | Lazarus et al. | Oct 1996 | A |
5562729 | Purdy | Oct 1996 | A |
5571168 | Toro | Nov 1996 | A |
5589563 | Ward et al. | Dec 1996 | A |
5591197 | Orth et al. | Jan 1997 | A |
5591198 | Boyle et al. | Jan 1997 | A |
5595571 | Jaffe | Jan 1997 | A |
5603698 | Roberts et al. | Feb 1997 | A |
5607442 | Fischell et al. | Mar 1997 | A |
5607445 | Summers | Mar 1997 | A |
5607465 | Camilli | Mar 1997 | A |
5609598 | Laufer et al. | Mar 1997 | A |
5613981 | Boyle et al. | Mar 1997 | A |
5624449 | Pham et al. | Apr 1997 | A |
5628791 | Bokros et al. | May 1997 | A |
5630829 | Lauterjung | May 1997 | A |
5632771 | Boatman et al. | May 1997 | A |
5634936 | Linden et al. | Jun 1997 | A |
5636641 | Fariabi | Jun 1997 | A |
5641324 | Bokros et al. | Jun 1997 | A |
5643312 | Fischell et al. | Jul 1997 | A |
5643317 | Pavcnik et al. | Jul 1997 | A |
5653727 | Wiktor | Aug 1997 | A |
5662675 | Polansky et al. | Sep 1997 | A |
5667523 | Bynon et al. | Sep 1997 | A |
5668288 | Storey et al. | Sep 1997 | A |
5669933 | Simon et al. | Sep 1997 | A |
5681346 | Orth et al. | Oct 1997 | A |
5683411 | Kavteladze et al. | Nov 1997 | A |
5690642 | Osborne et al. | Nov 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5702372 | Nelson | Dec 1997 | A |
5702421 | Schneidt | Dec 1997 | A |
5705181 | Cooper et al. | Jan 1998 | A |
5707389 | Louw et al. | Jan 1998 | A |
5709707 | Lock et al. | Jan 1998 | A |
5711969 | Patel et al. | Jan 1998 | A |
5713920 | Bezwada et al. | Feb 1998 | A |
5713950 | Cox | Feb 1998 | A |
5713953 | Vallana et al. | Feb 1998 | A |
5720777 | Jaffe | Feb 1998 | A |
5725519 | Penner | Mar 1998 | A |
5725534 | Rasmussen | Mar 1998 | A |
5725572 | Lam et al. | Mar 1998 | A |
5728158 | Lau et al. | Mar 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5733325 | Robinson et al. | Mar 1998 | A |
5733337 | Carr, Jr. et al. | Mar 1998 | A |
5735893 | Lau et al. | Apr 1998 | A |
5741327 | Frantzen | Apr 1998 | A |
5749919 | Blanc | May 1998 | A |
5755776 | Al-Saadon | May 1998 | A |
5755777 | Chuter | May 1998 | A |
5755778 | Kleshinski | May 1998 | A |
5755781 | Jayaraman | May 1998 | A |
5759192 | Saunders | Jun 1998 | A |
5762625 | Igaki | Jun 1998 | A |
5766238 | Lau et al. | Jun 1998 | A |
5769780 | Hata et al. | Jun 1998 | A |
5769796 | Palermo et al. | Jun 1998 | A |
5772632 | Forman | Jun 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5776188 | Shepherd et al. | Jul 1998 | A |
5779670 | Melman et al. | Jul 1998 | A |
5779729 | Severini | Jul 1998 | A |
5792114 | Fiore | Aug 1998 | A |
5792144 | Fischell et al. | Aug 1998 | A |
5797952 | Klein | Aug 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5797953 | Tekulve | Sep 1998 | A |
5800456 | Maeda et al. | Sep 1998 | A |
5800526 | Andersen et al. | Sep 1998 | A |
5807404 | Richter | Sep 1998 | A |
5810847 | Laufer et al. | Sep 1998 | A |
5814061 | Osborne et al. | Sep 1998 | A |
5824041 | Freislinger et al. | Oct 1998 | A |
5824042 | Lombardi et al. | Oct 1998 | A |
5824045 | Alt | Oct 1998 | A |
5824049 | Ragheb et al. | Oct 1998 | A |
5824062 | Patke et al. | Oct 1998 | A |
5824063 | Cox | Oct 1998 | A |
5827237 | Macoviak et al. | Oct 1998 | A |
5833694 | Poncet | Oct 1998 | A |
5830209 | Savage et al. | Nov 1998 | A |
5833671 | Macoviak et al. | Nov 1998 | A |
5836964 | Richter et al. | Nov 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5843090 | Schuetz | Dec 1998 | A |
5843117 | Alt et al. | Dec 1998 | A |
5843180 | Jaffe et al. | Dec 1998 | A |
5843181 | Jaffe et al. | Dec 1998 | A |
5846247 | Unworth et al. | Dec 1998 | A |
5846261 | Kotula et al. | Dec 1998 | A |
5851232 | Lois | Dec 1998 | A |
5853422 | Huebsch et al. | Dec 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855600 | Alt | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5855602 | Angell | Jan 1999 | A |
5861003 | Latson et al. | Jan 1999 | A |
5865723 | Love | Feb 1999 | A |
5876445 | Andersen et al. | Mar 1999 | A |
5876448 | Thompson et al. | Mar 1999 | A |
5879305 | Yock et al. | Mar 1999 | A |
5879366 | Shaw et al. | Mar 1999 | A |
5879382 | Boneau | Mar 1999 | A |
5885619 | Patel et al. | Mar 1999 | A |
5891128 | Gia et al. | Apr 1999 | A |
5891193 | Robinson et al. | Apr 1999 | A |
5891195 | Klostermeyer et al. | Apr 1999 | A |
5895419 | Tweden et al. | Apr 1999 | A |
5895420 | Mirsch, II et al. | Apr 1999 | A |
5902334 | Dwyer et al. | May 1999 | A |
5907893 | Zadno-Azizi et al. | Jun 1999 | A |
5908452 | Bokros et al. | Jun 1999 | A |
5911732 | Hojeibane | Jun 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5926016 | Pattantyus | Jul 1999 | A |
5928248 | Acker | Jul 1999 | A |
5928258 | Kahn | Jul 1999 | A |
5935148 | Villar et al. | Aug 1999 | A |
5935161 | Robinson | Aug 1999 | A |
5937861 | Augustine | Aug 1999 | A |
5938682 | Hojeibane | Aug 1999 | A |
5944733 | Engelson | Aug 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5947995 | Samuels | Sep 1999 | A |
5947997 | Pavcnik et al. | Sep 1999 | A |
5954766 | Zadno-Azizi et al. | Sep 1999 | A |
5955110 | Patel et al. | Sep 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5960642 | Kim et al. | Oct 1999 | A |
5961546 | Robinson et al. | Oct 1999 | A |
5968096 | Whitson et al. | Oct 1999 | A |
5980565 | Jayaraman | Nov 1999 | A |
5980799 | Martakos et al. | Nov 1999 | A |
5981195 | Fuller et al. | Nov 1999 | A |
5993844 | Abraham et al. | Nov 1999 | A |
5997573 | Quijano et al. | Dec 1999 | A |
6004347 | McNamara et al. | Dec 1999 | A |
6007521 | Melman | Dec 1999 | A |
6010531 | Donlon et al. | Jan 2000 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6017363 | Hojeibane | Jan 2000 | A |
6022359 | Frantzen et al. | Feb 2000 | A |
6022374 | Imran | Feb 2000 | A |
6024690 | Lee et al. | Feb 2000 | A |
6027525 | Suh et al. | Feb 2000 | A |
6033398 | Farley et al. | Mar 2000 | A |
6036687 | Laufer et al. | Mar 2000 | A |
6042606 | Frantzen | Mar 2000 | A |
6053940 | Wijay | Apr 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6059757 | Macoviak et al. | May 2000 | A |
6059779 | Mills | May 2000 | A |
6059826 | Bokros | May 2000 | A |
6059827 | Fenton | May 2000 | A |
6063113 | Kavteladze et al. | May 2000 | A |
6074419 | Healy et al. | Jun 2000 | A |
6077281 | Das | Jun 2000 | A |
6077291 | Das | Jun 2000 | A |
6077295 | Limon et al. | Jun 2000 | A |
6077296 | Shokoohi et al. | Jun 2000 | A |
6080182 | Shaw et al. | Jun 2000 | A |
6090035 | Campbell | Jul 2000 | A |
6090127 | Globerman | Jul 2000 | A |
6096027 | Layne | Aug 2000 | A |
6096052 | Callister et al. | Aug 2000 | A |
6096070 | Ragheb et al. | Aug 2000 | A |
6099561 | Alt | Aug 2000 | A |
6099567 | Badylak et al. | Aug 2000 | A |
6100962 | Kinoshita et al. | Aug 2000 | A |
6110191 | Dehdashtian | Aug 2000 | A |
6110201 | Quijano et al. | Aug 2000 | A |
6110212 | Gregory | Aug 2000 | A |
6113623 | Sgro | Sep 2000 | A |
6117157 | Tekulve | Sep 2000 | A |
6117159 | Huebsch et al. | Sep 2000 | A |
6117979 | Hendriks et al. | Sep 2000 | A |
6123721 | Jang | Sep 2000 | A |
6126685 | Lenker | Oct 2000 | A |
6126686 | Badylak et al. | Oct 2000 | A |
6129755 | Mathis et al. | Oct 2000 | A |
6132460 | Thompson | Oct 2000 | A |
6132461 | Thompson | Oct 2000 | A |
6136025 | Barbut et al. | Oct 2000 | A |
6139575 | Shu et al. | Oct 2000 | A |
6143016 | Bleam | Nov 2000 | A |
6143022 | Shull et al. | Nov 2000 | A |
6146416 | Andersen et al. | Nov 2000 | A |
6149660 | Laufer et al. | Nov 2000 | A |
6149680 | Shelso | Nov 2000 | A |
6159237 | Alt et al. | Dec 2000 | A |
6162245 | Jayaraman | Dec 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6168617 | Blaeser et al. | Jan 2001 | B1 |
6174331 | Moe et al. | Jan 2001 | B1 |
6176875 | Lenker | Jan 2001 | B1 |
6178968 | Louw et al. | Jan 2001 | B1 |
6179858 | Squire et al. | Jan 2001 | B1 |
6183511 | Patke et al. | Feb 2001 | B1 |
6183512 | Howanec et al. | Feb 2001 | B1 |
6187036 | Shaolian et al. | Feb 2001 | B1 |
6187039 | Hiles et al. | Feb 2001 | B1 |
6190406 | Durerig et al. | Feb 2001 | B1 |
6193731 | Oppelt | Feb 2001 | B1 |
6197049 | Shaolian et al. | Mar 2001 | B1 |
6200336 | Pavcnik et al. | Mar 2001 | B1 |
6206907 | Marino et al. | Mar 2001 | B1 |
6206931 | Cook et al. | Mar 2001 | B1 |
6214029 | Thill et al. | Apr 2001 | B1 |
6216493 | Weston et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6231507 | Zikorus et al. | May 2001 | B1 |
6231561 | Frazier et al. | May 2001 | B1 |
6231598 | Berry | May 2001 | B1 |
6235050 | Quiachon et al. | May 2001 | B1 |
6235053 | Jang | May 2001 | B1 |
6238409 | Hojeibane | May 2001 | B1 |
6238416 | Sideris | May 2001 | B1 |
6241763 | Drasler et al. | Jun 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6254611 | Vrba | Jul 2001 | B1 |
6254631 | Thompson | Jul 2001 | B1 |
6254636 | Peredo | Jul 2001 | B1 |
6254642 | Taylor | Jul 2001 | B1 |
6264700 | Kilcoyne et al. | Jul 2001 | B1 |
6280467 | Leonhardt | Aug 2001 | B1 |
6233968 | Taheri | Sep 2001 | B1 |
6283990 | Kanesaka | Sep 2001 | B1 |
6287330 | Johansson et al. | Sep 2001 | B1 |
6287332 | Bolz et al. | Sep 2001 | B1 |
6287334 | Moll et al. | Sep 2001 | B1 |
6287336 | Globerman et al. | Sep 2001 | B1 |
6293966 | Frantzen | Sep 2001 | B1 |
6296657 | Brucker | Oct 2001 | B1 |
6299604 | Ragheb et al. | Oct 2001 | B1 |
6299635 | Frantzen | Oct 2001 | B1 |
6299636 | Schmitt et al. | Oct 2001 | B1 |
6299637 | Shaolian | Oct 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6312474 | Francis et al. | Nov 2001 | B1 |
6312549 | Huang et al. | Nov 2001 | B1 |
6315793 | Bokros et al. | Nov 2001 | B1 |
6319281 | Patel | Nov 2001 | B1 |
6325819 | Pavcnik et al. | Dec 2001 | B1 |
6328727 | Frazier et al. | Dec 2001 | B1 |
6328763 | Love et al. | Dec 2001 | B1 |
6334052 | Nordstrand | Dec 2001 | B1 |
6334871 | Dor et al. | Jan 2002 | B1 |
6334872 | Termin et al. | Jan 2002 | B1 |
6336938 | Kavteladze et al. | Jan 2002 | B1 |
6338730 | Bonutti et al. | Jan 2002 | B1 |
6338740 | Carpentier | Jan 2002 | B1 |
6340366 | Wijay | Jan 2002 | B2 |
6342067 | Mathis et al. | Jan 2002 | B1 |
6342070 | Nguyen-Thien-Nhon | Jan 2002 | B1 |
6346074 | Roth | Feb 2002 | B1 |
6348065 | Brown et al. | Feb 2002 | B1 |
6352554 | De Paulis | Mar 2002 | B2 |
6355052 | Neuss et al. | Mar 2002 | B1 |
6355056 | Pinheiro | Mar 2002 | B1 |
6355070 | Andersen et al. | Mar 2002 | B1 |
6358228 | Tubman et al. | Mar 2002 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6358284 | Fearnot et al. | Mar 2002 | B1 |
6368338 | Konya et al. | Apr 2002 | B1 |
6371961 | Osborne et al. | Apr 2002 | B1 |
6371983 | Lane | Apr 2002 | B1 |
6375679 | Martyn et al. | Apr 2002 | B1 |
6375989 | Badylak et al. | Apr 2002 | B1 |
6379365 | Diaz | Apr 2002 | B1 |
6379710 | Badylak | Apr 2002 | B1 |
6383216 | Kavteladze et al. | May 2002 | B1 |
6383832 | Stone | May 2002 | B1 |
6395018 | Castaneda | May 2002 | B1 |
6409752 | Boatman et al. | Jun 2002 | B1 |
6415631 | Weston et al. | Jul 2002 | B1 |
6416542 | Marcade et al. | Jul 2002 | B1 |
6425914 | Wallace et al. | Jul 2002 | B1 |
6425916 | Garrison | Jul 2002 | B1 |
6428570 | Globerman | Aug 2002 | B1 |
6440163 | Swanson et al. | Aug 2002 | B1 |
6440164 | DiMatteo et al. | Aug 2002 | B1 |
6444229 | Voytik-Harbin et al. | Sep 2002 | B2 |
6451052 | Burmeister et al. | Sep 2002 | B1 |
6458137 | Klint | Oct 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6464720 | Boatman | Oct 2002 | B2 |
6471718 | Staehle | Oct 2002 | B1 |
6478819 | Moe | Nov 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6485500 | Kokish et al. | Nov 2002 | B1 |
6485510 | Camrud et al. | Nov 2002 | B1 |
6488702 | Besselink | Dec 2002 | B1 |
6494909 | Greenhalgh | Dec 2002 | B2 |
6503272 | Duerig et al. | Jan 2003 | B2 |
6508824 | Flaherty et al. | Jan 2003 | B1 |
6508833 | Pavcnik | Jan 2003 | B2 |
6508966 | Castro et al. | Jan 2003 | B1 |
6514063 | Acciai et al. | Feb 2003 | B2 |
6524336 | Papazoglou et al. | Feb 2003 | B1 |
6527800 | McGuckin, Jr. et al. | Mar 2003 | B1 |
6530951 | Bates et al. | Mar 2003 | B1 |
6533807 | Wolinsky et al. | Mar 2003 | B2 |
6544291 | Taylor | Apr 2003 | B2 |
6547815 | Myers et al. | Apr 2003 | B2 |
6553801 | Chen | Apr 2003 | B2 |
6558415 | Thompson | May 2003 | B2 |
6558418 | Carpentier et al. | May 2003 | B2 |
6558429 | Taylor | May 2003 | B2 |
6562065 | Shanley | May 2003 | B1 |
6565597 | Fearnot et al. | May 2003 | B1 |
6565600 | Hojeibane | May 2003 | B2 |
6572650 | Abraham et al. | Jun 2003 | B1 |
6579221 | Peterson | Jun 2003 | B1 |
6579307 | Sarac | Jun 2003 | B2 |
6579311 | Makower | Jun 2003 | B1 |
6579538 | Spievack | Jun 2003 | B1 |
6580568 | Ozaki | Jun 2003 | B2 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6585761 | Taheri | Jul 2003 | B2 |
6589230 | Gla et al. | Jul 2003 | B2 |
6594880 | Elsberry | Jul 2003 | B2 |
6596021 | Lootz | Jul 2003 | B1 |
6598307 | Love et al. | Jul 2003 | B2 |
6599275 | Fischer, Jr. | Jul 2003 | B1 |
6602241 | Makower et al. | Aug 2003 | B2 |
6602286 | Strecker | Aug 2003 | B1 |
6605049 | Wagner et al. | Aug 2003 | B1 |
6613002 | Clark et al. | Sep 2003 | B1 |
6613086 | Moe et al. | Sep 2003 | B1 |
6616680 | Thielen | Sep 2003 | B1 |
6623506 | McGuckin, Jr. et al. | Sep 2003 | B2 |
6623508 | Shaw et al. | Sep 2003 | B2 |
6632196 | Houser | Oct 2003 | B1 |
6638300 | Frantzen | Oct 2003 | B1 |
6640412 | Iancea | Nov 2003 | B2 |
6656206 | Corcoran et al. | Dec 2003 | B2 |
6656216 | Hossainy et al. | Dec 2003 | B1 |
6663661 | Boneau | Dec 2003 | B2 |
6666885 | Moe | Dec 2003 | B2 |
6666886 | Tranquillo et al. | Dec 2003 | B1 |
6669724 | Park et al. | Dec 2003 | B2 |
6673100 | Diaz et al. | Jan 2004 | B2 |
6676694 | Weiss | Jan 2004 | B1 |
6676698 | McGuckin, Jr. et al. | Jan 2004 | B2 |
6678962 | Love et al. | Jan 2004 | B1 |
6685739 | DiMatteo et al. | Feb 2004 | B2 |
6689123 | Pinchasik | Feb 2004 | B2 |
6692458 | Forman et al. | Feb 2004 | B2 |
6706026 | Goldstein et al. | Mar 2004 | B1 |
6716241 | Wilder et al. | Apr 2004 | B2 |
6720402 | Langer et al. | Apr 2004 | B2 |
6726715 | Sutherland | Apr 2004 | B2 |
6730064 | Ragheb et al. | May 2004 | B2 |
6730117 | Tseng et al. | May 2004 | B1 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6746489 | Dua et al. | Jun 2004 | B2 |
6749622 | McGuckin, Jr. et al. | Jun 2004 | B2 |
6752826 | Holloway et al. | Jun 2004 | B2 |
6752828 | Thornton | Jun 2004 | B2 |
6761735 | Eberhardt et al. | Jul 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6783499 | Schwartz | Aug 2004 | B2 |
6786922 | Schaeffer | Sep 2004 | B2 |
6790214 | Kraemer et al. | Sep 2004 | B2 |
6790218 | Jayaraman | Sep 2004 | B2 |
6790237 | Stinson | Sep 2004 | B2 |
6821292 | Pazienza et al. | Nov 2004 | B2 |
6823576 | Austin | Nov 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6843802 | Villalobos et al. | Jan 2005 | B1 |
6859986 | Jackson | Mar 2005 | B2 |
6878162 | Bales et al. | Apr 2005 | B2 |
6896690 | Lambrecht | May 2005 | B1 |
6908481 | Cribier | Jun 2005 | B2 |
6911037 | Gainor et al. | Jun 2005 | B2 |
6915560 | Austin | Jul 2005 | B2 |
6918929 | Udipi et al. | Jul 2005 | B2 |
6921378 | O'Keefe et al. | Jul 2005 | B2 |
6932829 | Majercak | Aug 2005 | B2 |
6939377 | Jayaraman et al. | Sep 2005 | B2 |
6945978 | Hyde | Sep 2005 | B1 |
6945989 | Betelia et al. | Sep 2005 | B1 |
6949113 | Van Tassel et al. | Sep 2005 | B2 |
6949116 | Solymar et al. | Sep 2005 | B2 |
6953332 | Kurk et al. | Oct 2005 | B1 |
6958076 | Acosta | Oct 2005 | B2 |
6960220 | Marino et al. | Nov 2005 | B2 |
6962603 | Brown et al. | Nov 2005 | B1 |
6974474 | Pavcnik et al. | Dec 2005 | B2 |
6976995 | Mathis et al. | Dec 2005 | B2 |
6994092 | Van der Burg et al. | Feb 2006 | B2 |
6994717 | Konya et al. | Feb 2006 | B2 |
7011671 | Welch | Mar 2006 | B2 |
7018403 | Pienknagura | Mar 2006 | B1 |
7018404 | Holmberg et al. | Mar 2006 | B2 |
7018406 | Seguin | Mar 2006 | B2 |
7018407 | Wright et al. | Mar 2006 | B1 |
7025777 | Moore | Apr 2006 | B2 |
7025780 | Gabbay | Apr 2006 | B2 |
7025923 | Harhen et al. | Apr 2006 | B2 |
7029493 | Majercak et al. | Apr 2006 | B2 |
7044966 | Svanidze et al. | May 2006 | B2 |
7060088 | Fischell et al. | Jun 2006 | B1 |
7070616 | Majercak et al. | Jul 2006 | B2 |
7081131 | Thornton | Jul 2006 | B2 |
7101381 | Ford et al. | Sep 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7101396 | Svanidze et al. | Sep 2006 | B2 |
7118600 | Dua et al. | Oct 2006 | B2 |
7125418 | Duran et al. | Oct 2006 | B2 |
7128073 | van der Burg et al. | Oct 2006 | B1 |
7128756 | Lowe et al. | Oct 2006 | B2 |
7128757 | Osborne et al. | Oct 2006 | B2 |
7128759 | Osborne et al. | Oct 2006 | B2 |
7144410 | Marino et al. | Dec 2006 | B2 |
7147661 | Chobotov et al. | Dec 2006 | B2 |
7153324 | Case et al. | Dec 2006 | B2 |
7160320 | Duran | Jan 2007 | B2 |
7163556 | Xie et al. | Jan 2007 | B2 |
7172625 | Shu et al. | Feb 2007 | B2 |
7179270 | Makower | Feb 2007 | B2 |
7182779 | Acosta et al. | Feb 2007 | B2 |
7186789 | Hossainy et al. | Mar 2007 | B2 |
7195641 | Palmaz et al. | Mar 2007 | B2 |
7232462 | Schaeffer | Jun 2007 | B2 |
7247167 | Gabbay | Jul 2007 | B2 |
7258697 | Cox et al. | Aug 2007 | B1 |
7261732 | Justino | Aug 2007 | B2 |
7273492 | Cheng et al. | Sep 2007 | B2 |
7288105 | Oman et al. | Oct 2007 | B2 |
7303571 | Makower et al. | Dec 2007 | B2 |
7323010 | Verona et al. | Jan 2008 | B2 |
7338520 | Bailey et al. | Mar 2008 | B2 |
7347869 | Hojeibane et al. | Mar 2008 | B2 |
7351256 | Hojeibane et al. | Apr 2008 | B2 |
7354455 | Stinson | Apr 2008 | B2 |
7361189 | Case et al. | Apr 2008 | B2 |
7364587 | Dong et al. | Apr 2008 | B2 |
7377938 | Sarac et al. | May 2008 | B2 |
7381219 | Salahieh et al. | Jun 2008 | B2 |
7399315 | Iobbi | Jul 2008 | B2 |
7402171 | Osborne | Jul 2008 | B2 |
7435257 | Lashinski et al. | Oct 2008 | B2 |
7445630 | Lashinski et al. | Nov 2008 | B2 |
7445631 | Salahieh et al. | Nov 2008 | B2 |
7452371 | Pavcnik et al. | Nov 2008 | B2 |
7491942 | Black et al. | Feb 2009 | B2 |
7503928 | Case et al. | Mar 2009 | B2 |
7520894 | Pavcnik et al. | Apr 2009 | B2 |
7524331 | Birdsall | Apr 2009 | B2 |
7524332 | Osborne et al. | Apr 2009 | B2 |
7534259 | Lashinski et al. | May 2009 | B2 |
7544205 | Flagle et al. | Jun 2009 | B2 |
7544207 | Osborne et al. | Jun 2009 | B2 |
7547322 | Sarac et al. | Jun 2009 | B2 |
7556645 | Lashinski et al. | Jul 2009 | B2 |
7563276 | Osborne et al. | Jul 2009 | B2 |
7563277 | Case et al. | Jul 2009 | B2 |
7566336 | Corcoran et al. | Jul 2009 | B2 |
7569071 | Haverkost et al. | Aug 2009 | B2 |
7582110 | Case et al. | Sep 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7594927 | Majercak et al. | Sep 2009 | B2 |
7604661 | Pavcnik et al. | Oct 2009 | B2 |
7618447 | Case et al. | Nov 2009 | B2 |
7625395 | Case et al. | Dec 2009 | B2 |
7625399 | Case et al. | Dec 2009 | B2 |
7628803 | Pavcnik et al. | Dec 2009 | B2 |
7628804 | Flagle et al. | Dec 2009 | B2 |
7637937 | Case et al. | Dec 2009 | B2 |
7641686 | Lashinski et al. | Jan 2010 | B2 |
7648527 | Agnew | Jan 2010 | B2 |
7653455 | Cinader, Jr. | Jan 2010 | B2 |
7655288 | Bauman et al. | Feb 2010 | B2 |
7655584 | Biran et al. | Feb 2010 | B2 |
7658759 | Case et al. | Feb 2010 | B2 |
7658762 | Lashinski et al. | Feb 2010 | B2 |
7659219 | Biran et al. | Feb 2010 | B2 |
7670366 | Case et al. | Mar 2010 | B2 |
7678144 | Bailey et al. | Mar 2010 | B2 |
7686844 | Case et al. | Mar 2010 | B2 |
7736385 | Agnew | Jun 2010 | B2 |
7739971 | Chambers et al. | Jun 2010 | B2 |
7745532 | Ruberti et al. | Jun 2010 | B2 |
7806921 | Hoffman | Oct 2010 | B2 |
7815923 | Johnson et al. | Oct 2010 | B2 |
7819836 | Levine et al. | Oct 2010 | B2 |
7846199 | Paul, Jr. et al. | Dec 2010 | B2 |
7846203 | Cribier | Dec 2010 | B2 |
7850510 | Farnsworth et al. | Dec 2010 | B2 |
7854759 | Shirley | Dec 2010 | B2 |
7861570 | Thomas | Jan 2011 | B2 |
7871430 | Pavcnik et al. | Jan 2011 | B2 |
7918882 | Pavcnik et al. | Apr 2011 | B2 |
7935144 | Lashinski et al. | May 2011 | B2 |
7942887 | Kraemer et al. | May 2011 | B2 |
7955375 | Agnew | Jun 2011 | B2 |
7955376 | Osborne et al. | Jun 2011 | B2 |
7955377 | Melsheimer | Jun 2011 | B2 |
7964206 | Suokas et al. | Jun 2011 | B2 |
7979150 | Lin et al. | Jul 2011 | B2 |
7993410 | Shin et al. | Aug 2011 | B2 |
8012201 | Lashinski et al. | Sep 2011 | B2 |
8038708 | Case et al. | Oct 2011 | B2 |
8038710 | Fearnot et al. | Oct 2011 | B2 |
8048500 | Drumheller et al. | Nov 2011 | B2 |
8048503 | Farnsworth et al. | Nov 2011 | B2 |
8057532 | Hoffman | Nov 2011 | B2 |
8057540 | Letac et al. | Nov 2011 | B2 |
8092522 | Paul, Jr. et al. | Jan 2012 | B2 |
8109990 | Paul et al. | Feb 2012 | B2 |
8118877 | Brauker et al. | Feb 2012 | B2 |
8128686 | Paul, Jr. et al. | Mar 2012 | B2 |
8129477 | Zhang et al. | Mar 2012 | B1 |
8133213 | Lashinski et al. | Mar 2012 | B2 |
8133500 | Ringeisen et al. | Mar 2012 | B2 |
8157810 | Case et al. | Apr 2012 | B2 |
8157857 | Case et al. | Apr 2012 | B2 |
8197534 | Osborne et al. | Jun 2012 | B2 |
8211165 | McIntosh et al. | Jul 2012 | B1 |
8221492 | Case et al. | Jul 2012 | B2 |
8252043 | Case et al. | Aug 2012 | B2 |
8257429 | Pavcnik | Sep 2012 | B2 |
8273117 | Palumbo et al. | Sep 2012 | B2 |
8276533 | Chambers et al. | Oct 2012 | B2 |
8292938 | Case | Oct 2012 | B2 |
8303648 | Grewe et al. | Nov 2012 | B2 |
8303649 | Agnew et al. | Nov 2012 | B2 |
8308796 | Lashinski et al. | Nov 2012 | B2 |
8313526 | Hoffman et al. | Nov 2012 | B2 |
8317853 | Agnew | Nov 2012 | B2 |
8323332 | Agnew | Dec 2012 | B2 |
8337545 | Osborne | Dec 2012 | B2 |
8351126 | Peng | Jan 2013 | B2 |
8366741 | Chin et al. | Feb 2013 | B2 |
8366743 | Zeng | Feb 2013 | B2 |
8377118 | Lashinski et al. | Feb 2013 | B2 |
8403977 | Case et al. | Mar 2013 | B2 |
8403979 | Paul, Jr. | Mar 2013 | B2 |
8470020 | Schaeffer et al. | Jun 2013 | B2 |
8475512 | Hunt | Jul 2013 | B2 |
8475516 | Paul et al. | Jul 2013 | B2 |
8506621 | Agnew et al. | Aug 2013 | B2 |
8556881 | Lashinski et al. | Oct 2013 | B2 |
8568477 | Lashinski et al. | Oct 2013 | B2 |
8617205 | Pavcnik et al. | Dec 2013 | B2 |
8652197 | Paul et al. | Feb 2014 | B2 |
8663320 | Chambers et al. | Mar 2014 | B2 |
8679175 | Paul, Jr. et al. | Mar 2014 | B2 |
8702746 | Tekulve et al. | Apr 2014 | B2 |
8771338 | Schaeffer et al. | Jul 2014 | B2 |
10722365 | Chambers | Jul 2020 | B2 |
20010001128 | Holman et al. | May 2001 | A1 |
20010004707 | Dereume et al. | Jun 2001 | A1 |
20010004715 | Duran | Jun 2001 | A1 |
20010007956 | Letac et al. | Jul 2001 | A1 |
20010011187 | Pavcnik et al. | Aug 2001 | A1 |
20010016770 | Allen et al. | Aug 2001 | A1 |
20010018610 | Limon | Aug 2001 | A1 |
20010020189 | Taylor | Sep 2001 | A1 |
20010020190 | Taylor | Sep 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010025197 | Shu et al. | Sep 2001 | A1 |
20010034537 | Shaw et al. | Oct 2001 | A1 |
20010037129 | Thill | Nov 2001 | A1 |
20010039450 | Pavcnik | Nov 2001 | A1 |
20010041930 | Globerman et al. | Nov 2001 | A1 |
20010044648 | Wolinsky et al. | Nov 2001 | A1 |
20010049553 | De Paulis et al. | Dec 2001 | A1 |
20020002400 | Drasler et al. | Jan 2002 | A1 |
20020019665 | Dehdashtian et al. | Feb 2002 | A1 |
20020029994 | Schon | Mar 2002 | A1 |
20020032414 | Ragheb et al. | Mar 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020038128 | Turovkiy et al. | Mar 2002 | A1 |
20020052642 | Cox et al. | May 2002 | A1 |
20020052651 | Myers et al. | May 2002 | A1 |
20020055772 | McGuckin, Jr. et al. | May 2002 | A1 |
20020065552 | Jayaraman et al. | May 2002 | A1 |
20020065554 | Streeter | May 2002 | A1 |
20020068866 | Zikorus | Jun 2002 | A1 |
20020072794 | Gabbay | Jun 2002 | A1 |
20020099439 | Schwartz et al. | Jul 2002 | A1 |
20020111339 | Klausener et al. | Aug 2002 | A1 |
20020111647 | Khairkhahan et al. | Aug 2002 | A1 |
20020115559 | Batchelor et al. | Aug 2002 | A1 |
20020120338 | Boyer et al. | Aug 2002 | A1 |
20020123786 | Gittings | Sep 2002 | A1 |
20020123790 | White et al. | Sep 2002 | A1 |
20020123800 | Taheri | Sep 2002 | A1 |
20020123802 | Snyders | Sep 2002 | A1 |
20020129820 | Ryan et al. | Sep 2002 | A1 |
20020138131 | Solovay et al. | Sep 2002 | A1 |
20020138135 | Duerig et al. | Sep 2002 | A1 |
20020169475 | Gainor et al. | Nov 2002 | A1 |
20020173843 | Peredo et al. | Nov 2002 | A1 |
20020177890 | Lenker | Nov 2002 | A1 |
20020177894 | Acosta et al. | Nov 2002 | A1 |
20020177899 | Eum | Nov 2002 | A1 |
20020179098 | Makower | Dec 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20020187288 | Lim et al. | Dec 2002 | A1 |
20020193871 | Beyersdorf et al. | Dec 2002 | A1 |
20020198563 | Gainor et al. | Dec 2002 | A1 |
20030014104 | Cribier | Jan 2003 | A1 |
20030014126 | Patel et al. | Jan 2003 | A1 |
20030018968 | Avnet | Jan 2003 | A1 |
20030023302 | Moe et al. | Jan 2003 | A1 |
20030023303 | Palmaz et al. | Jan 2003 | A1 |
20030028213 | Thill et al. | Feb 2003 | A1 |
20030028233 | Vardi et al. | Feb 2003 | A1 |
20030033009 | Gabbay | Feb 2003 | A1 |
20030036794 | Ragheb et al. | Feb 2003 | A1 |
20030040792 | Gabbay | Feb 2003 | A1 |
20030040808 | Stack et al. | Feb 2003 | A1 |
20030055483 | Gumm | Mar 2003 | A1 |
20030055492 | Shaolian | Mar 2003 | A1 |
20030055496 | Cai et al. | Mar 2003 | A1 |
20030069646 | Stinson | Apr 2003 | A1 |
20030083730 | Stinson | May 2003 | A1 |
20030083741 | Woo et al. | May 2003 | A1 |
20030093071 | Hauck et al. | May 2003 | A1 |
20030093108 | Avellanet et al. | May 2003 | A1 |
20030093144 | Jang | May 2003 | A1 |
20030097172 | Shalev et al. | May 2003 | A1 |
20030109922 | Peterson et al. | Jun 2003 | A1 |
20030114913 | Spenser | Jun 2003 | A1 |
20030114919 | McQuiston et al. | Jun 2003 | A1 |
20030120263 | Ouriel et al. | Jun 2003 | A1 |
20030125790 | Fastovsky et al. | Jul 2003 | A1 |
20030125791 | Sequin et al. | Jul 2003 | A1 |
20030125795 | Pavcnik et al. | Jul 2003 | A1 |
20030130713 | Stewart et al. | Jul 2003 | A1 |
20030130726 | Thorpe et al. | Jul 2003 | A1 |
20030135266 | Chew et al. | Jul 2003 | A1 |
20030139805 | Holmberg et al. | Jul 2003 | A1 |
20030139819 | Beer et al. | Jul 2003 | A1 |
20030144670 | Pavcnik et al. | Jul 2003 | A1 |
20030144694 | Chanduszko et al. | Jul 2003 | A1 |
20030149471 | Briana et al. | Aug 2003 | A1 |
20030153972 | Helmus | Aug 2003 | A1 |
20030153974 | Spenser et al. | Aug 2003 | A1 |
20030163190 | LaFont et al. | Aug 2003 | A1 |
20030171824 | Abraham et al. | Sep 2003 | A1 |
20030176911 | Iancea et al. | Sep 2003 | A1 |
20030176912 | Chuter et al. | Sep 2003 | A1 |
20030176914 | Rabkin et al. | Sep 2003 | A1 |
20030181968 | Xie et al. | Sep 2003 | A1 |
20030181973 | Sahota | Sep 2003 | A1 |
20030181974 | Xie et al. | Sep 2003 | A1 |
20030187500 | Jansen et al. | Oct 2003 | A1 |
20030191495 | Ryan et al. | Oct 2003 | A1 |
20030191525 | Thornton | Oct 2003 | A1 |
20030195618 | Abraham et al. | Oct 2003 | A1 |
20030199747 | Michlitsch | Oct 2003 | A1 |
20030199767 | Cespedes | Oct 2003 | A1 |
20030199768 | Cespedes | Oct 2003 | A1 |
20030206860 | Bleyer et al. | Nov 2003 | A1 |
20030208224 | Broome | Nov 2003 | A1 |
20030208254 | Shortt | Nov 2003 | A1 |
20030208261 | Thorpe | Nov 2003 | A1 |
20030209835 | Chun | Nov 2003 | A1 |
20030212431 | Brady et al. | Nov 2003 | A1 |
20030220683 | Minasian et al. | Nov 2003 | A1 |
20030225445 | Derus | Dec 2003 | A1 |
20030225446 | Hartley | Dec 2003 | A1 |
20030225449 | Denison | Dec 2003 | A1 |
20030236443 | Cespedes | Dec 2003 | A1 |
20030236568 | Hojeibane et al. | Dec 2003 | A1 |
20040006380 | Buck et al. | Jan 2004 | A1 |
20040015230 | Moll | Jan 2004 | A1 |
20040015232 | Salazar | Jan 2004 | A1 |
20040019374 | Hojeibane et al. | Jan 2004 | A1 |
20040024444 | Moore | Feb 2004 | A1 |
20040024447 | Haverich | Feb 2004 | A1 |
20040024452 | Kruse et al. | Feb 2004 | A1 |
20040029993 | Klee et al. | Feb 2004 | A1 |
20040034409 | Heublein et al. | Feb 2004 | A1 |
20040044401 | Bales et al. | Mar 2004 | A1 |
20040044407 | Verona | Mar 2004 | A1 |
20040047909 | Ragheb | Mar 2004 | A1 |
20040049262 | Obermiller et al. | Mar 2004 | A1 |
20040049266 | Anduiza et al. | Mar 2004 | A1 |
20040059411 | Strecker | Mar 2004 | A1 |
20040064067 | Ward | Apr 2004 | A1 |
20040073155 | Laufer et al. | Apr 2004 | A1 |
20040073230 | Mulholland et al. | Apr 2004 | A1 |
20040073238 | Makower | Apr 2004 | A1 |
20040073242 | Chanduszko | Apr 2004 | A1 |
20040073297 | Rohde et al. | Apr 2004 | A1 |
20040078053 | Berg et al. | Apr 2004 | A1 |
20040093017 | Chanduszko | May 2004 | A1 |
20040093061 | Acosta et al. | May 2004 | A1 |
20040093070 | Hojeibane et al. | May 2004 | A1 |
20040093073 | Lowe et al. | May 2004 | A1 |
20040098030 | Makower et al. | May 2004 | A1 |
20040098079 | Hartley | May 2004 | A1 |
20040098098 | McGucking et al. | May 2004 | A1 |
20040102806 | Broome et al. | May 2004 | A1 |
20040102834 | Nakano et al. | May 2004 | A1 |
20040102855 | Shank | May 2004 | A1 |
20040106985 | Jang | Jun 2004 | A1 |
20040111145 | Serino et al. | Jun 2004 | A1 |
20040117004 | Osborne et al. | Jun 2004 | A1 |
20040117010 | Houston et al. | Jun 2004 | A1 |
20040117031 | Stack et al. | Jun 2004 | A1 |
20040122448 | Levine | Jun 2004 | A1 |
20040127981 | Rahdert et al. | Jul 2004 | A1 |
20040127982 | Machold et al. | Jul 2004 | A1 |
20040137042 | Hiles et al. | Jul 2004 | A1 |
20040138737 | Davidson et al. | Jul 2004 | A1 |
20040143277 | Marino et al. | Jul 2004 | A1 |
20040143291 | Corcoran et al. | Jul 2004 | A1 |
20040143292 | Marino et al. | Jul 2004 | A1 |
20040143293 | Marino et al. | Jul 2004 | A1 |
20040143294 | Corcoran et al. | Jul 2004 | A1 |
20040148000 | Bilge | Jul 2004 | A1 |
20040158331 | Stack et al. | Aug 2004 | A1 |
20040166169 | Malaviya et al. | Aug 2004 | A1 |
20040167566 | Beulke et al. | Aug 2004 | A1 |
20040167619 | Case et al. | Aug 2004 | A1 |
20040080352 | Bleyer | Sep 2004 | A1 |
20040172141 | Stack et al. | Sep 2004 | A1 |
20040176799 | Chanduszko et al. | Sep 2004 | A1 |
20040180042 | Cook et al. | Sep 2004 | A1 |
20040186558 | Pavcnik | Sep 2004 | A1 |
20040210301 | Obermiller | Oct 2004 | A1 |
20040210306 | Quijano et al. | Oct 2004 | A1 |
20040213756 | Michal et al. | Oct 2004 | A1 |
20040215333 | Duran et al. | Oct 2004 | A1 |
20040220610 | Kreidler et al. | Nov 2004 | A1 |
20040224868 | Meyerhoff et al. | Nov 2004 | A1 |
20040225344 | Hoffa et al. | Nov 2004 | A1 |
20040225348 | Case et al. | Nov 2004 | A1 |
20040225352 | Osborne et al. | Nov 2004 | A1 |
20040225356 | Frater | Nov 2004 | A1 |
20040230222 | Van der Burg et al. | Nov 2004 | A1 |
20040230287 | Hartley | Nov 2004 | A1 |
20040243216 | Gregorich | Dec 2004 | A1 |
20040243218 | Schaeffer | Dec 2004 | A1 |
20040243219 | Fischer et al. | Dec 2004 | A1 |
20040243222 | Osborne et al. | Dec 2004 | A1 |
20040249439 | Richter et al. | Dec 2004 | A1 |
20040254640 | Sutherland et al. | Dec 2004 | A1 |
20040260229 | Meir | Dec 2004 | A1 |
20040260328 | Zvuloni et al. | Dec 2004 | A1 |
20040260340 | Jacobs et al. | Dec 2004 | A1 |
20040260389 | Case | Dec 2004 | A1 |
20040260393 | Rahdert et al. | Dec 2004 | A1 |
20040267191 | Gifford, III et al. | Dec 2004 | A1 |
20040267306 | Blaeser et al. | Dec 2004 | A1 |
20050004659 | Von Oepen et al. | Jan 2005 | A1 |
20050010248 | Lafontaine | Jan 2005 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050010287 | Macoviak et al. | Jan 2005 | A1 |
20050033398 | Seguin | Feb 2005 | A1 |
20050034735 | Deem et al. | Feb 2005 | A1 |
20050038501 | Moore, Jr. et al. | Feb 2005 | A1 |
20050043708 | Gleeson et al. | Feb 2005 | A1 |
20050043759 | Chanduszko | Feb 2005 | A1 |
20050049634 | Chopra | Mar 2005 | A1 |
20050055079 | Duran et al. | Mar 2005 | A1 |
20050059923 | Gamboa | Mar 2005 | A1 |
20050060024 | Lee et al. | Mar 2005 | A1 |
20050065547 | Marino et al. | Mar 2005 | A1 |
20050065548 | Marino et al. | Mar 2005 | A1 |
20050065614 | Stinson | Mar 2005 | A1 |
20050070794 | Deal et al. | Mar 2005 | A1 |
20050070821 | Deal et al. | Mar 2005 | A1 |
20050075713 | Biancucci et al. | Apr 2005 | A1 |
20050075725 | Rowe | Apr 2005 | A1 |
20050075726 | Svanidze et al. | Apr 2005 | A1 |
20050075728 | Nguyen et al. | Apr 2005 | A1 |
20050085843 | Opolski et al. | Apr 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050092335 | Bertrand | May 2005 | A1 |
20050096734 | Majercak et al. | May 2005 | A1 |
20050096735 | Hojeibane et al. | May 2005 | A1 |
20050096736 | Case | May 2005 | A1 |
20050113686 | Peckham et al. | May 2005 | A1 |
20050113910 | Paniagua | May 2005 | A1 |
20050125032 | Whisenant et al. | Jun 2005 | A1 |
20050125050 | Carter | Jun 2005 | A1 |
20050137676 | Richardson et al. | Jun 2005 | A1 |
20050137681 | Shoemaker et al. | Jun 2005 | A1 |
20050143801 | Aboul-Hosn | Jun 2005 | A1 |
20050143806 | Phillips | Jun 2005 | A1 |
20050143807 | Pavcnik | Jun 2005 | A1 |
20050149459 | Andreas et al. | Jul 2005 | A1 |
20050154405 | Kraemer et al. | Jul 2005 | A1 |
20050163818 | Sung et al. | Jul 2005 | A1 |
20050171592 | Majercak | Aug 2005 | A1 |
20050182483 | Osborne et al. | Aug 2005 | A1 |
20050187565 | Baker et al. | Aug 2005 | A1 |
20050187614 | Agnew | Aug 2005 | A1 |
20050191496 | Maschke | Sep 2005 | A1 |
20050192626 | Widomski et al. | Sep 2005 | A1 |
20050192627 | Whisenant et al. | Sep 2005 | A1 |
20050203568 | Burg et al. | Sep 2005 | A1 |
20050216077 | Mathis et al. | Sep 2005 | A1 |
20050222661 | Case et al. | Oct 2005 | A1 |
20050228434 | Amplatz et al. | Oct 2005 | A1 |
20050228479 | Pavcnik et al. | Oct 2005 | A1 |
20050228486 | Case | Oct 2005 | A1 |
20050228495 | Macoviak | Oct 2005 | A1 |
20050228505 | Cornet et al. | Oct 2005 | A1 |
20050234509 | Widomski et al. | Oct 2005 | A1 |
20050234541 | Hunt et al. | Oct 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050240255 | Schaeffer | Oct 2005 | A1 |
20050249772 | Malaviya et al. | Nov 2005 | A1 |
20050251201 | Roue et al. | Nov 2005 | A1 |
20050256532 | Nayak et al. | Nov 2005 | A1 |
20050261759 | Lambrecht et al. | Nov 2005 | A1 |
20050267524 | Chanduszko | Dec 2005 | A1 |
20050267526 | Wahr et al. | Dec 2005 | A1 |
20050267560 | Bates | Dec 2005 | A1 |
20050267573 | Macoviak et al. | Dec 2005 | A9 |
20050273124 | Chanduszko | Dec 2005 | A1 |
20050273153 | Clerc et al. | Dec 2005 | A1 |
20050273160 | Lashinski et al. | Dec 2005 | A1 |
20050283187 | Longson | Dec 2005 | A1 |
20050288706 | Widomski et al. | Dec 2005 | A1 |
20050288786 | Chanduszko | Dec 2005 | A1 |
20060004433 | Greenberg | Jan 2006 | A1 |
20060004436 | Amarant et al. | Jan 2006 | A1 |
20060009800 | Christianson et al. | Jan 2006 | A1 |
20060015178 | Moaddeb et al. | Jan 2006 | A1 |
20060020332 | Lashinski et al. | Jan 2006 | A1 |
20060020334 | Lashinski et al. | Jan 2006 | A1 |
20060025844 | Majercak et al. | Feb 2006 | A1 |
20060030923 | Gunderson | Feb 2006 | A1 |
20060036282 | Wahr et al. | Feb 2006 | A1 |
20060041302 | Malewicz | Feb 2006 | A1 |
20060041319 | Taylor et al. | Feb 2006 | A1 |
20060047338 | Jenson et al. | Mar 2006 | A1 |
20060052816 | Bates et al. | Mar 2006 | A1 |
20060052821 | Abbott et al. | Mar 2006 | A1 |
20060058865 | Case et al. | Mar 2006 | A1 |
20060058889 | Case et al. | Mar 2006 | A1 |
20060064152 | Olson | Mar 2006 | A1 |
20060069430 | Rahdert et al. | Mar 2006 | A9 |
20060074352 | Case et al. | Apr 2006 | A1 |
20060074480 | Bales et al. | Apr 2006 | A1 |
20060089708 | Osse et al. | Apr 2006 | A1 |
20060100531 | Moser | May 2006 | A1 |
20060106418 | Seibold et al. | May 2006 | A1 |
20060106420 | Dolan et al. | May 2006 | A1 |
20060106454 | Osborne | May 2006 | A1 |
20060106456 | Machold et al. | May 2006 | A9 |
20060111770 | Pavcnik et al. | May 2006 | A1 |
20060111773 | Rittgers et al. | May 2006 | A1 |
20060116548 | Case et al. | Jun 2006 | A1 |
20060116572 | Case | Jun 2006 | A1 |
20060122646 | Corcoran et al. | Jun 2006 | A1 |
20060136044 | Osborne et al. | Jun 2006 | A1 |
20060136045 | Flagle et al. | Jun 2006 | A1 |
20060155327 | Briganti et al. | Jul 2006 | A1 |
20060167468 | Gabbay | Jul 2006 | A1 |
20060173532 | Flagle et al. | Aug 2006 | A1 |
20060178729 | Thielen et al. | Aug 2006 | A1 |
20060178730 | Hill et al. | Aug 2006 | A1 |
20060178740 | Stacchino et al. | Aug 2006 | A1 |
20060184239 | Andrieu et al. | Aug 2006 | A1 |
20060195004 | Jarvik | Aug 2006 | A1 |
20060200196 | Zang et al. | Sep 2006 | A1 |
20060201996 | Hodde | Sep 2006 | A1 |
20060210597 | Hiles | Sep 2006 | A1 |
20060210603 | Williams et al. | Sep 2006 | A1 |
20060212107 | Case et al. | Sep 2006 | A1 |
20060212110 | Osborne et al. | Sep 2006 | A1 |
20060212111 | Case et al. | Sep 2006 | A1 |
20060216326 | Pacetti | Sep 2006 | A1 |
20060217760 | Widomski et al. | Sep 2006 | A1 |
20060217761 | Opolski | Sep 2006 | A1 |
20060229670 | Bates | Oct 2006 | A1 |
20060229702 | Agnew | Oct 2006 | A1 |
20060230592 | Heaney | Oct 2006 | A1 |
20060235467 | DeVore | Oct 2006 | A1 |
20060235511 | Osborne | Oct 2006 | A1 |
20060241675 | Johnson et al. | Oct 2006 | A1 |
20060241744 | Beith | Oct 2006 | A1 |
20060247762 | Acosta et al. | Nov 2006 | A1 |
20060253188 | Case | Nov 2006 | A1 |
20060259115 | Case et al. | Nov 2006 | A1 |
20060259128 | Pavcnik et al. | Nov 2006 | A1 |
20060259136 | Nguyen | Nov 2006 | A1 |
20060265053 | Hunt | Nov 2006 | A1 |
20060271030 | Francis et al. | Nov 2006 | A1 |
20060271159 | Gregorich et al. | Nov 2006 | A1 |
20060276813 | Greenberg | Dec 2006 | A1 |
20060276882 | Case | Dec 2006 | A1 |
20060282157 | Hill et al. | Dec 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20070016306 | Dua et al. | Jan 2007 | A1 |
20070021826 | Case | Jan 2007 | A1 |
20070027460 | Case et al. | Feb 2007 | A1 |
20070027535 | Purdy et al. | Feb 2007 | A1 |
20070027549 | Godin | Feb 2007 | A1 |
20070038291 | Case | Feb 2007 | A1 |
20070043431 | Melsheimer | Feb 2007 | A1 |
20070056346 | Spenser | Mar 2007 | A1 |
20070061002 | Paul, Jr. et al. | Mar 2007 | A1 |
20070061009 | Spenser | Mar 2007 | A1 |
20070088424 | Greenberg | Apr 2007 | A1 |
20070093887 | Case et al. | Apr 2007 | A1 |
20070100435 | Case | May 2007 | A1 |
20070106372 | Osborne et al. | May 2007 | A1 |
20070112423 | Chu | May 2007 | A1 |
20070112437 | Shank | May 2007 | A1 |
20070129738 | Kraemer et al. | Jun 2007 | A1 |
20070135826 | Zaver et al. | Jun 2007 | A1 |
20070162057 | Kraemer et al. | Jul 2007 | A1 |
20070162058 | Kraemer et al. | Jul 2007 | A1 |
20070162103 | Case | Jul 2007 | A1 |
20070167961 | Kraemer et al. | Jul 2007 | A1 |
20070173919 | Maschke | Jul 2007 | A1 |
20070185560 | Roeder et al. | Aug 2007 | A1 |
20070185565 | Schwammenthal et al. | Aug 2007 | A1 |
20070208429 | Leahy | Sep 2007 | A1 |
20070213813 | Segesser et al. | Sep 2007 | A1 |
20070225798 | Gregorich | Sep 2007 | A1 |
20070227518 | Case | Oct 2007 | A1 |
20070233237 | Krivoruchko | Oct 2007 | A1 |
20070239273 | Allen | Oct 2007 | A1 |
20070244545 | Birdsall et al. | Oct 2007 | A1 |
20070260263 | Case et al. | Nov 2007 | A1 |
20070260327 | Case et al. | Nov 2007 | A1 |
20070270931 | Leanna | Nov 2007 | A1 |
20070270932 | Headley | Nov 2007 | A1 |
20070270937 | Leanna | Nov 2007 | A1 |
20070288086 | Kalmann et al. | Dec 2007 | A1 |
20070288087 | Gabbay | Dec 2007 | A1 |
20080009934 | Schneider | Jan 2008 | A1 |
20080046071 | Pavcnik | Feb 2008 | A1 |
20080051879 | Case et al. | Feb 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080091235 | Sirota | Apr 2008 | A1 |
20080103582 | Randall et al. | May 2008 | A1 |
20080125860 | Webler et al. | May 2008 | A1 |
20080140110 | Spence | Jun 2008 | A1 |
20080200936 | Kraemer et al. | Aug 2008 | A1 |
20080200937 | Kraemer et al. | Aug 2008 | A1 |
20080208215 | Kraemer et al. | Aug 2008 | A1 |
20080221656 | Hartley | Sep 2008 | A1 |
20080228206 | Kraemer et al. | Sep 2008 | A1 |
20080228285 | Kraemer et al. | Sep 2008 | A1 |
20080243246 | Ryan et al. | Oct 2008 | A1 |
20080249538 | Kraemer et al. | Oct 2008 | A1 |
20080249609 | Shanley | Oct 2008 | A1 |
20080249612 | Osborne et al. | Oct 2008 | A1 |
20080249619 | Stacchino et al. | Oct 2008 | A1 |
20080275470 | Kraemer et al. | Nov 2008 | A1 |
20080281337 | Kraemer et al. | Nov 2008 | A1 |
20080287966 | Kraemer et al. | Nov 2008 | A1 |
20080312735 | Thorpe et al. | Dec 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090018649 | Jaffe et al. | Jan 2009 | A1 |
20090062836 | Kurrus | Mar 2009 | A1 |
20090062844 | Tekulve | Mar 2009 | A1 |
20090082858 | Nugent et al. | Mar 2009 | A1 |
20090088836 | Bishop et al. | Apr 2009 | A1 |
20090099653 | Suri et al. | Apr 2009 | A1 |
20090105813 | Chambers | Apr 2009 | A1 |
20090118712 | Carter et al. | May 2009 | A1 |
20090132037 | Hoffman | May 2009 | A1 |
20090177275 | Case | Jul 2009 | A1 |
20090216321 | Osborne et al. | Aug 2009 | A1 |
20090234434 | Johnson et al. | Sep 2009 | A1 |
20090240320 | Tuval et al. | Sep 2009 | A1 |
20090248132 | Bloom et al. | Oct 2009 | A1 |
20090264991 | Paul et al. | Oct 2009 | A1 |
20090270965 | Sinha et al. | Oct 2009 | A1 |
20090287300 | Dave et al. | Nov 2009 | A1 |
20090292350 | Eberhardt | Nov 2009 | A1 |
20100023114 | Chambers et al. | Jan 2010 | A1 |
20100030246 | Pavcnik et al. | Feb 2010 | A1 |
20100030259 | Pavcnik et al. | Feb 2010 | A1 |
20100030314 | Case et al. | Feb 2010 | A1 |
20100036484 | Hariton | Feb 2010 | A1 |
20100057191 | Pavcnik et al. | Mar 2010 | A1 |
20100063577 | Case et al. | Mar 2010 | A1 |
20100114296 | Case et al. | May 2010 | A1 |
20100114300 | Case et al. | May 2010 | A1 |
20100121461 | Sobrino-Serrano et al. | May 2010 | A1 |
20100121462 | Sobrino-Serrano et al. | May 2010 | A1 |
20100131055 | Case et al. | May 2010 | A1 |
20100137998 | Sobrino-Serrano et al. | Jun 2010 | A1 |
20100174364 | Hoffman | Jul 2010 | A1 |
20100185277 | Braido | Jul 2010 | A1 |
20110054497 | Kraemer et al. | Mar 2011 | A1 |
20110087198 | Carter et al. | Apr 2011 | A1 |
20110087337 | Forsell | Apr 2011 | A1 |
20110098800 | Braido | Apr 2011 | A1 |
20110160753 | Bastin | Jun 2011 | A1 |
20110190796 | Kraemer et al. | Aug 2011 | A1 |
20110190905 | Behan | Aug 2011 | A1 |
20110202078 | Kraemer et al. | Aug 2011 | A1 |
20120053681 | Alkhatib | Mar 2012 | A1 |
20120071969 | Li | Mar 2012 | A1 |
20120078347 | Braido | Mar 2012 | A1 |
20120089223 | Nguyen | Apr 2012 | A1 |
20120130476 | Paul et al. | May 2012 | A1 |
20120185038 | Fish | Jul 2012 | A1 |
20120197390 | Alkhatib | Aug 2012 | A1 |
20120203327 | Case et al. | Aug 2012 | A1 |
20120253446 | Osborne et al. | Oct 2012 | A1 |
20120253450 | Case et al. | Oct 2012 | A1 |
20120323306 | Case et al. | Dec 2012 | A1 |
20120330413 | Pavcnik | Dec 2012 | A1 |
20130018453 | Case et al. | Jan 2013 | A1 |
20130079867 | Hoffman et al. | Mar 2013 | A1 |
20130079868 | Agnew | Mar 2013 | A1 |
20130110254 | Osborne | May 2013 | A1 |
20130116720 | Theobald et al. | May 2013 | A1 |
20130123768 | Harlan | May 2013 | A1 |
20130150956 | Yohanan | Jun 2013 | A1 |
20130226291 | Pavcnik et al. | Aug 2013 | A1 |
20130289706 | Schaeffer et al. | Oct 2013 | A1 |
20140000112 | Braido | Jan 2014 | A1 |
20140005776 | Braido | Jan 2014 | A1 |
20140107691 | Lashinski | Apr 2014 | A1 |
20140143236 | Thompson et al. | May 2014 | A1 |
20140155987 | Paul et al. | Jun 2014 | A1 |
20140155997 | Braido | Jun 2014 | A1 |
20140163667 | Lashinski et al. | Jun 2014 | A1 |
20140228937 | Krieger et al. | Aug 2014 | A1 |
20150230923 | Levi | Aug 2015 | A1 |
20160067031 | Kassab | Mar 2016 | A1 |
20160175095 | Dienno | Jun 2016 | A1 |
20170128212 | Chambers | May 2017 | A1 |
Number | Date | Country |
---|---|---|
2003265468 | Aug 2002 | AU |
2002248669 | Oct 2002 | AU |
2004220576 | Sep 2004 | AU |
2381787 | Mar 2001 | CA |
2401996 | Mar 2001 | CA |
2403030 | Sep 2002 | CA |
2518867 | Sep 2004 | CA |
2523262 | Nov 2004 | CA |
2246526 | Mar 1973 | DE |
19851846 | May 2000 | DE |
10223399 | Dec 2003 | DE |
103546 | Mar 1984 | EP |
0350302 | Jan 1990 | EP |
0357003 | Mar 1990 | EP |
0386936 | Sep 1990 | EP |
0520126 | Nov 1991 | EP |
0460428 | Dec 1991 | EP |
0493788 | Jul 1992 | EP |
0592410 | Apr 1994 | EP |
0657147 | Jun 1995 | EP |
0732089 | Sep 1996 | EP |
0800801 | Jun 1997 | EP |
0792627 | Sep 1997 | EP |
0808614 | Nov 1997 | EP |
0850607 | Jul 1998 | EP |
0938880 | Sep 1999 | EP |
1057460 | Dec 2000 | EP |
1179321 | Feb 2002 | EP |
1230901 | Aug 2002 | EP |
1362563 | Nov 2003 | EP |
1472996 | Apr 2004 | EP |
1615595 | Apr 2004 | EP |
1579886 | Sep 2005 | EP |
1434538 | Jan 2007 | EP |
1626681 | Jul 2009 | EP |
1603492 | Dec 2009 | EP |
1615593 | Jan 2010 | EP |
2163224 | Mar 2010 | EP |
2201911 | Jun 2010 | EP |
1229865 | Nov 2010 | EP |
2120795 | Jul 2011 | EP |
2222247 | Aug 2012 | EP |
1887980 | Sep 2012 | EP |
1928512 | Nov 2012 | EP |
1659992 | Mar 2013 | EP |
2722678 | Jul 1994 | FR |
2785174 | May 2000 | FR |
2788217 | Jul 2000 | FR |
2828091 | Feb 2003 | FR |
1598111 | Apr 1977 | GB |
2056023 | Mar 1981 | GB |
0386936 | Aug 2004 | GB |
S61137556 | Jun 1986 | JP |
S62-227352 | Oct 1987 | JP |
02-307480 | Dec 1990 | JP |
4383707 | Oct 2009 | JP |
4589395 | Dec 2010 | JP |
4624984 | Dec 2010 | JP |
4940388 | Mar 2012 | JP |
1258406 | Sep 1986 | SU |
1271508 | Nov 1986 | SU |
1371701 | Feb 1988 | SU |
WO8302225 | Jul 1983 | WO |
WO8501651 | Apr 1985 | WO |
WO9014804 | Dec 1990 | WO |
WO9117720 | Nov 1991 | WO |
WO9209247 | Nov 1991 | WO |
WO9217118 | Oct 1992 | WO |
WO9407560 | Apr 1994 | WO |
WO9527448 | Oct 1995 | WO |
WO9637167 | Nov 1996 | WO |
WO9640008 | Dec 1996 | WO |
WO9640011 | Dec 1996 | WO |
WO9724082 | Jul 1997 | WO |
WO9725937 | Jul 1997 | WO |
WO9728744 | Aug 1997 | WO |
WO9732543 | Sep 1997 | WO |
WO9819732 | Nov 1997 | WO |
WO9822045 | May 1998 | WO |
WO9825636 | Jun 1998 | WO |
WO9825637 | Jun 1998 | WO |
WO9826291 | Jun 1998 | WO |
WO9827868 | Jul 1998 | WO |
WO9846165 | Oct 1998 | WO |
WO9858600 | Dec 1998 | WO |
WO9915224 | Apr 1999 | WO |
WO9933414 | Jul 1999 | WO |
WO9959503 | Nov 1999 | WO |
WO9962431 | Dec 1999 | WO |
WO0040176 | Jul 2000 | WO |
WO0042950 | Jul 2000 | WO |
WO0047134 | Aug 2000 | WO |
0067679 | Nov 2000 | WO |
WO0064380 | Nov 2000 | WO |
WO0067661 | Nov 2000 | WO |
WO0112105 | Feb 2001 | WO |
0119285 | Mar 2001 | WO |
WO0128459 | Apr 2001 | WO |
WO0130275 | May 2001 | WO |
WO0149213 | Jul 2001 | WO |
WO0154625 | Aug 2001 | WO |
WO0156500 | Aug 2001 | WO |
WO0166035 | Sep 2001 | WO |
WO0166037 | Sep 2001 | WO |
WO0166043 | Sep 2001 | WO |
WO0166190 | Sep 2001 | WO |
WO0174273 | Oct 2001 | WO |
WO200183017 | Nov 2001 | WO |
WO0207601 | Jan 2002 | WO |
WO2002024119 | Mar 2002 | WO |
WO0236045 | May 2002 | WO |
WO0239888 | May 2002 | WO |
WO0241764 | May 2002 | WO |
WO0243620 | Jun 2002 | WO |
WO0249541 | Jun 2002 | WO |
WO02102284 | Dec 2002 | WO |
WO03002165 | Jan 2003 | WO |
WO03011195 | Feb 2003 | WO |
WO03030776 | Apr 2003 | WO |
WO03030782 | Apr 2003 | WO |
WO03047468 | Jun 2003 | WO |
WO03063733 | Aug 2003 | WO |
WO03088872 | Oct 2003 | WO |
WO03101346 | Dec 2003 | WO |
WO2003101346 | Dec 2003 | WO |
WO2004016200 | Feb 2004 | WO |
WO2004016201 | Feb 2004 | WO |
WO2004045703 | Jun 2004 | WO |
WO2004080352 | Sep 2004 | WO |
WO2004082528 | Sep 2004 | WO |
WO2004082530 | Sep 2004 | WO |
WO2004089253 | Oct 2004 | WO |
WO2004091449 | Oct 2004 | WO |
2004096100 | Nov 2004 | WO |
WO2004093745 | Nov 2004 | WO |
WO2004103222 | Dec 2004 | WO |
WO2004105651 | Dec 2004 | WO |
WO2005011535 | Feb 2005 | WO |
WO2005020612 | Mar 2005 | WO |
WO05062931 | Jul 2005 | WO |
WO2005082289 | Sep 2005 | WO |
WO2005099623 | Oct 2005 | WO |
WO2005099628 | Oct 2005 | WO |
WO2006026325 | Mar 2006 | WO |
WO2006028821 | Mar 2006 | WO |
WO2006031436 | Mar 2006 | WO |
2006050460 | May 2006 | WO |
WO2006071245 | Jul 2006 | WO |
WO2006124647 | Nov 2006 | WO |
WO2006125055 | Nov 2006 | WO |
WO2007047945 | Apr 2007 | WO |
WO2007061801 | May 2007 | WO |
WO2007092274 | Aug 2007 | WO |
WO07108857 | Sep 2007 | WO |
2007123658 | Nov 2007 | WO |
WO2007130614 | Nov 2007 | WO |
WO2007139677 | Dec 2007 | WO |
WO2007142935 | Dec 2007 | WO |
WO2008073582 | Jun 2008 | WO |
WO2008094706 | Aug 2008 | WO |
WO2008101083 | Aug 2008 | WO |
WO08150529 | Dec 2008 | WO |
WO2009052340 | Apr 2009 | WO |
WO2009073774 | Jun 2009 | WO |
WO2009088957 | Jul 2009 | WO |
WO2009129481 | Oct 2009 | WO |
WO2010042950 | Apr 2010 | WO |
WO2010080884 | Jul 2010 | WO |
WO2010091188 | Aug 2010 | WO |
WO2010099209 | Sep 2010 | WO |
WO2011109450 | Sep 2011 | WO |
WO2012051489 | Apr 2012 | WO |
WO2013120082 | Aug 2013 | WO |
WO03092554 | Nov 2013 | WO |
WO2014124356 | Aug 2014 | WO |
Entry |
---|
Kinney, T.E., et al., “Acute, reversible tricuspid insufficiency: creation in canine model,” Am. J. Physiol. Heart Circ. Physiol. 260: H638-H641, 1991. |
Bai, Yuan, et al., “Percutaneous establishment of tricuspid regugitation: an experimental model for transcatheter tricuspid valve replacement,” Chin. Med. J. 2010; 123(7), pp. 806-809. |
Lamba, et al., “Degradation of Polyurethanes,” Polyurethanes in Biomedical Applications, 181-204, 1998. |
Matthias Chiquet, “Regulation of extracellular matrix gene expression by mechanical stress,” Matrix Biol., 417-426, 1999. |
Marcy Wong, Mark Siegrist, Xuesong Cao, “Cyclic compression of articular cartilage explants is associated with progressive consolidation and altered expression pattern of extracellular matrix proteins,” Matrix Biology, 391-399, 1999. |
Alan J. Grodzinsky, Marc E. Levenston, Moonsoo Jin, Eliot H. Frank, “Cartilage Tissue Remodeling in Response to Mechanical Forces,” Annual Review of Biomedical Engineering, 691-713, 2000. |
V.C. Mudera, R. Pleass, M. Eastwood, R. Tarnuzzer, G. Schultz, P. Khaw, D.A. Mcgrouther, R.A. Brown, “Molecular Responses of Human Dermal Fibroblasts to Dual Cues: Contact Guidance and Mechanical Load,” Cell Motility and the Cytoskeleton, 45: 1-9, 2000. |
Christof Schild, Beat Trueb, “Mechanical Stress is Required for High-Level Expression of Connective Tissue Growth Factor,” Experimental Cell Research, 274: 83-91, 2002. |
Heeschen, Christopher, et al., “Nicotine Stimulates Angiogensis and Promotes Tumor Growth and Atherosclerosis”, Nature Medicine vol. 7, No. 7, (Jul. 2001), pp. 833-839. |
Johnson, Chad, et al., “Matrix Metalloproteinase-9 is Required for Adequate Angiogenic Revascularization of Ischemic Tissues”, Circulation Research, Feb. 6, 2004, No. 94, pp. 262-268. |
Jux, Christian, et al., “A New Biological Matrix for Septal Occlusion”, Journal of Interventional Cardiology, vol. 16, No. 2, (2003), pp. 149-152. |
King, Terry D., et al., “Secundum Atrial Septal Defect-Nonoperative Closure During Cardiac Catheterization”, JAMA, vol. 235, No. 23, Jun. 7, 1978, pp. 2506-2509. |
Mullen, Michael J., et al., “BioSTAR Evaluation STudy (BEST) A Prospective, Multicenter, Phase I Clinic Trial to Evaluate the Feasibility, Efficacy, and Safety of the BioSTAR Bioabsorbable Septal Repair Implant for the Closure of Atrial-Level Shunts”, Circulation, Oct. 31, 2006, pp. 19621967. |
Oguchi, M., et al., “Mucosa-adhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis”, International Journal of Radiation Oncology Biology Physics, Mar. 15, 1998, vol. 40, No. 5, p. 1033-1037. |
Pavcnik, Dusan et al., “Monodisk: Device for Percutaneous Transcatheter Closure of Cardiac Septal Defects”, Cardiovasc Intervent Radio (1993) vol. 16, pp. 308-312. |
Rashkind, William J., “Transcatheter Treatment of Congenital Heart Disease”, Circulation vol. 67, No. 4, Apr. 1983, pp. 711-716. |
Sideris, E.B. et al., “Transvenous Atrial Septal Defect Occlusion in Piglets with a ‘Buttoned’ Double-Disk Device”, Circulation, vol. 81, No. 1, Jan. 1990, pp. 312-318. |
Jux, Christian, et al., “Interventional Atrial Septal Defect Closure Using a Totally Bioresorbable Occluder Matrix”, JACC, vol. 48, No. 1 (2006), pp. 161-169. |
Babic, Uros U., et al., “Transcatheter Closure of Atrial Septal Defects”, The Lancet, Sep. 1, 1990, pp. 566-567. |
Bhattathiri, VN, et al., “Influence of plasma GSH level on acute radiation mucositis of the oral cavity”, International Journal of Radiation Oncology Biology Physics (1994), vol. 29, No. 2, pp. 383-386. |
Braun, M., et al., “Transcatheter Closure of Patent Foramen Ovale (PFO) in Patients With Paradoxical Embolism”, European Heart Journal (2004), vol. 25, pp. 424-430. |
Das, Gladwin S., et al., “Experimental Atrial Septal Defect Closure With a New, Transcatheter, Self-Centering Device”, Circulation, vol. 88, No. 4, Part 1, Oct. 1993, pp. 1754-1764. |
Lurie, Fedor Mechanism of Venous Valve Closure and Role of the Valve in Circulation: A New Concept, J Vasc Surg 2003;38:955-61. Elsevier, Amsterdam, The Netherlands. |
Lurie, Fedor, The Mechanism of Venous Valve Closure in Normal Physiologic Conditions, J Vasc Surg 2002;35:713-17. Elsevier, Amsterdam, The Netherlands. |
Van Bemmelen, Paul S. and Fedor Lurie, Letters to the Editor, Regarding “The Mechanism of Venous Valve Closure in Normal Physiological Conditions”, J Vasc Surg 2003; 37(1) 237-38. Elsevier, Amsterdam, The Netherlands. |
Garcia-Rinaldi, Raul, Implantation of Cryopreserved Allograft Pulmonary Monocusp Patch, Tex Heart Inst J 2002;29:92-99. Texas Heart Institute, Houston, TX, USA. |
Garcia-Rinaldi, Raul, Femoral Vein Valve Incompetence: Treatment with a Xenograft Monocusp Patch, J Vasc Surg 1986; 932-35. Elsevier, Amsterdam, The Netherlands. |
Dana E. Perrin, James P. English, “Polycaprolactone,” Handbook of Bioabsorbable Polymers, 1997, 63-76. |
Yuan et al. Geometrical Design and Finite Element Analysis on the Bioprosthetic Heart Valve. International Journal of Innovative Computing, Information and Control. vol. 3 No. 5. Oct. 2007. pp. 1289-1299. [abstract]. |
Yi-Shuan Li, John Y.-J Shyy, Song Li, Jongdae Lee, Bing US, Michael Karin, Shu Chien, “The Ras-JNK Pathway Is Involved in Shear-Induced Gene Expression,” Molecular and Cellular Biology, 1996, 5947-5954. |
Wai Hung Wong, David J. Mooney, “Synthesis and Properties of Biodegradable Polymers Used as Synthetic Matrices for Tissue Engineering,” I synthetic Biodegradable Polymer Scaffolds, 1997, 51-82. |
Schneider (Eur.) AG v. Scimed Life Sys., 852 F. Supp. 813 (D. Minn. 1994). |
Bergan, John J., et al., “Chronic Venous Disease,” N. Engl. J. Med. 2006; 355: 488-98. |
Dougal et al., “Stent Design: Implications for Restenosis,” Rev. Cardiovasc Med. 3 (suppl. 5), S16-S22 (2002). |
Shu Chien, Song Li, John Y-J Shyy, “Effects of Mechanical Forces on Signal Transdution and Gene Expression in Endothelial Cells,” Hypertension 31, 162-169, 1998. |
Stephen Badylak, Ph.D., M.D., Klod Lokini, Ph.D., Bob Tullius, M.S., Abby Simmons-Byrd, R.V.T., and Robert Morff, PH.D., “Morphologic Study of Small Intestinal Submucosa as a Body Wall Repair Device,” Journal of Surgical Research, 103, 190-202 (2002). |
Elias Brountzos, Md, Dusan Pavcnik, Md, PhD, Hans A. Timmermans, BFA, Christopher Corless, Md, PhD, Barry T. Uchida, BS, Edith S, Nihsen, BA, Manabu Nakata, Md, PhD, Maria Schoder, Md, John A. Kaufman, Md, Frederick S. Keller, Md, and Josef Rosch, Md, “Remodeling of Suspended Small Intestinal Submucosa Venous Valve: An Experimental Study in Sheep to Assess the Host Cells' Origin,” J. Vasc. Interv. Radiol, 2003 14:349-356. |
Stephen S. Kim, Satoshi Kaihara, Mark S. Benvenuto, Byung-Soo Kim, David J. Mooney, and Joseph P. Vacanti, “Small Intestinal Submucosa as a Small-Caliber Venous Graft: A Novel Model for Hepatocyte Transplantation on Synthetic Biodegradable Polymer Scaffolds with Direct Access to the Portal Venous System,” Journal of Pediatric Surgery, vol. 34, No. 1 (1999) 124-128. |
G.E. Sandusky, Jr., S.F. Badylak, R.J. Morff, W.D. Johnson, and G. Lantz, “Histologic Findings After In Vivo Placement of Small Intestine Submucosal Vascular Grafts and Saphenous Vein Grafts in the Carotid Artery in Dogs,” American Journal of Pathology, vol. 140, No. 2 1992, 317-324. |
D.K. Gilding, A.M. Reed, “Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1,” Polymer, 1997, vol. 20, 1459-1464. |
D.K. Gilding, “Biodegradable Polymers,” Biocompatibility of Clinical Implant Materials, Chap. 9, pp. 209-232, 1981. |
Gabriel Helmlinger, Bradford C. Berk, Robert M. Nerem, “Calcium responses of endothelial cell monolayers subjected to pulsatile and steady laminar flow differ,” Am. J. Physiol. Cell Physiol., 269: C367-C375, 1995. |
Matthias Chiquet, Mark Matthisson, Manuel Koch, Michael Tannheimer, Ruth Chiquet-Ehrismann, “Regulation of extracellular matrix synthesis by mechanical stress,” Biochem. Cell Biol. 74, 737-744 (1996). |
United States Patent and Trademark Office, Office Action for U.S. Appl. No. 14/377,619, dated Jul. 6, 2015, pp. 1-188. |
United States Patent and Trademark Office, Office Action for U.S. Appl. No. 14/377,619, dated Dec. 18, 2015, pp. 1-17. |
United States Patent and Trademark Office, Office Action for U.S. Appl. No. 14/377,619, dated Sep. 8, 2016, pp. 1-13. |
United States Patent and Trademark Office, Office Action for U.S. Appl. No. 14/377,619, dated Apr. 6, 2017, pp. 1-24. |
United States Patent and Trademark Office, Office Action for U.S. Appl. No. 14/377,619, dated Nov. 1, 2017, pp. 1-33. |
United States Patent and Trademark Office, Office Action for U.S. Appl. No. 14/377,619, dated Jul. 3, 2018, pp. 1-16. |
United States Patent and Trademark Office, Office Action for U.S. Appl. No. 14/377,619, dated Nov. 21, 2018, pp. 1-11. |
Number | Date | Country | |
---|---|---|---|
20180055635 A1 | Mar 2018 | US |
Number | Date | Country | |
---|---|---|---|
61763107 | Feb 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14176364 | Feb 2014 | US |
Child | 15804049 | US |